Altria (MO) 10-Q 25 Oct 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Oct. 15, 2018
Document And Entity Information [Abstract]
Document type	10-Q
Amendment Tag	false
Document period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3
Trading Symbol	mo
Entity Registrant Name	ALTRIA GROUP, INC.
Entity Central Index Key	764,180
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock, Shares Outstanding		1,879,045,481

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2018	Dec. 31, 2017	Dec. 31, 2016
Assets
Cash and cash equivalents	$ 2,393	$ 1,253
Receivables	187	142
Inventories:
Leaf tobacco	794	941
Other raw materials	188	170
Work in process	506	560
Finished product	589	554
Inventory, net	2,077	2,225
Income taxes	84	461
Other current assets	424	263
Total current assets	5,165	4,344
Property, plant and equipment, at cost	4,861	4,879
Less accumulated depreciation	2,970	2,965
Property, plant and equipment, net	1,891	1,914
Goodwill	5,307	5,307
Other intangible assets, net	12,385	12,400
Investment in AB InBev	17,825	17,952
Finance assets, net	848	899
Other assets	532	386
Total Assets	43,953	43,202
Liabilities
Current portion of long-term debt	2,007	864
Accounts payable	289	374
Accrued liabilities:
Marketing	690	695
Employment costs	147	188
Settlement charges	3,230	2,442
Other	775	971
Dividends payable	1,508	1,258
Total current liabilities	8,646	6,792
Long-term debt	11,896	13,030
Deferred income taxes	5,427	5,247
Accrued pension costs	260	445
Accrued postretirement health care costs	1,983	1,987
Other liabilities	207	283
Total liabilities	28,419	27,784
Contingencies (Note 10)
Redeemable noncontrolling interest	38	38
Stockholders’ Equity
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued)	935	935
Additional paid-in capital	5,959	5,952
Earnings reinvested in the business	43,805	42,251
Accumulated other comprehensive losses	(2,034)	(1,897)
Cost of repurchased stock (925,893,647 shares at September 30, 2018 and 904,702,125 shares at December 31, 2017)	(33,171)	(31,864)
Total stockholders’ equity attributable to Altria	15,494	15,377
Noncontrolling interests	2	3
Total stockholders’ equity	15,496	15,380	$ 12,773
Total Liabilities and Stockholders’ Equity	$ 43,953	$ 43,202

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Common stock, par value (usd per share)	$ 0.3333	$ 0.3333
Common stock, shares issued (shares)	2,805,961,317	2,805,961,317
Shares repurchased (shares)	925,893,647	904,702,125

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
Net revenues	$ 6,837	$ 6,729	$ 19,250	$ 19,475
Cost of sales	2,037	1,952	5,509	5,719
Excise taxes on products	1,545	1,606	4,409	4,695
Gross profit	3,255	3,171	9,332	9,061
Marketing, administration and research costs	700	574	1,959	1,681
Asset impairment and exit costs	(2)	8	2	24
Operating (expense) income	2,557	2,589	7,371	7,356
Interest and other debt expense, net	159	169	503	525
Net periodic benefit income, excluding service cost	(21)	(18)	(37)	(37)
Earnings from equity investment in AB InBev	(189)	(169)	(759)	(332)
Loss (gain) on AB InBev/SABMiller business combination	0	(37)	33	(445)
Earnings before income taxes and equity earnings of subsidiaries	2,608	2,644	7,631	7,645
Provision for income taxes	664	777	1,915	2,386
Net earnings	1,944	1,867	5,716	5,259
Net earnings attributable to noncontrolling interests	(1)	(1)	(3)	(3)
Net earnings attributable to Altria	$ 1,943	$ 1,866	$ 5,713	$ 5,256
Per share data:
Basic and diluted earnings per share attributable to Altria (usd per share)	$ 1.03	$ 0.97	$ 3.02	$ 2.72
Dividends declared (usd per share)	$ 0.8		$ 2.20	$ 1.88

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Earnings - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Statement of Comprehensive Income [Abstract]
Net earnings	$ 1,944	$ 1,867	$ 5,716	$ 5,259
Other comprehensive earnings (losses), net of deferred income taxes:
Benefit plans	39	31	126	96
AB InBev	(422)	(139)	(262)	9
Currency translation adjustments and other	1	0	(1)	1
Other comprehensive (losses) earnings, net of deferred income taxes	(382)	(108)	(137)	106
Comprehensive earnings	1,562	1,759	5,579	5,365
Comprehensive earnings attributable to noncontrolling interests	(1)	(1)	(3)	(3)
Comprehensive earnings attributable to Altria	$ 1,561	$ 1,758	$ 5,576	$ 5,362

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions		Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Earnings Reinvested in the Business [Member]	Accumulated Other Comprehensive Losses [Member]	Cost of Repurchased Stock [Member]	Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2016		$ 12,773	$ 935	$ 5,893	$ 36,906	$ (2,052)	$ (28,912)	$ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	[1]	10,222			10,222			0
Other comprehensive earnings (losses), net of deferred income taxes		155				155
Stock award activity		24		59			(35)
Cash dividends declared		(4,877)			(4,877)
Repurchases of common stock		(2,917)					(2,917)
Ending balance at Dec. 31, 2017		15,380	935	5,952	42,251	(1,897)	(31,864)	3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	[1]	5,713			5,713			0
Other comprehensive earnings (losses), net of deferred income taxes		(137)				(137)
Stock award activity		17		7			10
Cash dividends declared		(4,159)			(4,159)
Repurchases of common stock		(1,317)					(1,317)
Other		(1)						(1)
Ending balance at Sep. 30, 2018		$ 15,496	$ 935	$ 5,959	$ 43,805	$ (2,034)	$ (33,171)	$ 2
[1]	Amounts attributable to noncontrolling interests for the nine months ended September 30, 2018 and for the year ended December 31, 2017 exclude net earnings of $3 million and $5 million, respectively, due to the redeemable noncontrolling interest related to Stag’s Leap Wine Cellars, which is reported in the mezzanine equity section on the condensed consolidated balance sheets at September 30, 2018 and December 31, 2017.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Statement of Stockholders' Equity [Abstract]
Net earnings attributable to noncontrolling interests	$ 3	$ 5
Dividends declared (usd per share)	$ 2.20	$ 2.54

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash Provided by (Used in) Operating Activities
Net earnings	$ 5,716	$ 5,259
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	168	155
Deferred income tax provision (benefit)	215	(223)
Earnings from equity investment in AB InBev	(759)	(332)
Dividends from AB InBev	477	434
Loss (gain) on AB InBev/SABMiller business combination	33	(445)
Asset impairment and exit costs, net of cash paid	(24)	(30)
Cash effects of changes:
Receivables	(45)	4
Inventories	147	67
Accounts payable	(79)	(154)
Income taxes	308	341
Accrued liabilities and other current assets	(319)	(525)
Accrued settlement charges	757	(318)
Pension plan contributions	(19)	(18)
Pension provisions and postretirement, net	(19)	(70)
Other	9	(1)
Net cash provided by operating activities	6,566	4,144
Cash Provided by (Used in) Investing Activities
Capital expenditures	(132)	(151)
Proceeds from finance assets	0	133
Other	(5)	(184)
Net cash used in investing activities	(137)	(202)
Cash Used in Financing Activities
Repurchases of common stock	(1,317)	(2,359)
Dividends paid on common stock	(3,909)	(3,544)
Other	(25)	(47)
Net cash used in financing activities	(5,251)	(5,950)
Cash, cash equivalents and restricted cash:
Increase (decrease)	1,178	(2,008)
Balance at beginning of period	1,314	4,651
Balance at end of period	2,492	2,643
Cash, cash equivalents and restricted cash	$ 1,314	$ 4,651

Background and Basis of Present

Background and Basis of Presentation	9 Months Ended
	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation: Background At September 30, 2018 , Altria Group, Inc.’s (“Altria”) wholly-owned subsidiaries included Philip Morris USA Inc. (“PM USA”), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (“Middleton”), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly-owned subsidiary of PM USA; Sherman Group Holdings, LLC and its subsidiaries (“Nat Sherman”), which are engaged in the manufacture and sale of super premium cigarettes and the sale of premium cigars; and UST LLC (“UST”), which through its wholly-owned subsidiaries, including U.S. Smokeless Tobacco Company LLC (“USSTC”) and Ste. Michelle Wine Estates Ltd. (“Ste. Michelle”), is engaged in the manufacture and sale of smokeless tobacco products and wine. Altria’s other operating companies included Nu Mark LLC (“Nu Mark”), a wholly-owned subsidiary that is engaged in the manufacture and sale of innovative tobacco products, and Philip Morris Capital Corporation (“PMCC”), a wholly-owned subsidiary that maintains a portfolio of finance assets, substantially all of which are leveraged leases. Other Altria wholly-owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to certain Altria operating subsidiaries, and Altria Client Services LLC, which provides various support services in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs to Altria and its subsidiaries. Altria’s access to the operating cash flows of its wholly-owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries. At September 30, 2018 , Altria’s principal wholly-owned subsidiaries were not limited by long-term debt or other agreements in their ability to pay cash dividends or make other distributions with respect to their equity interests. At September 30, 2018 , Altria had an approximate 10.1% ownership of Anheuser-Busch InBev SA/NV (“AB InBev”), which Altria accounts for under the equity method of accounting using a one-quarter lag. Altria receives cash dividends on its interest in AB InBev if and when AB InBev pays such dividends. Dividends and Share Repurchases During the first quarter of 2018, Altria’s Board of Directors (the “Board of Directors”) approved a 6.1% increase in the quarterly dividend rate to $0.70 per share of Altria common stock versus the previous rate of $0.66 per share. During the third quarter of 2018, the Board of Directors approved an additional 14.3% increase in the quarterly dividend rate to $0.80 per share of Altria common stock, resulting in an overall quarterly dividend rate increase of 21.2% since the beginning of 2018. The current annualized dividend rate is $3.20 per share. Future dividend payments remain subject to the discretion of the Board of Directors. In July 2015, the Board of Directors authorized a $1.0 billion share repurchase program that it expanded to $3.0 billion in October 2016 and to $4.0 billion in July 2017 (as expanded, the “July 2015 share repurchase program”). In January 2018, Altria completed the July 2015 share repurchase program. Under this program, Altria repurchased a total of 58.7 million shares of its common stock at an average price of $68.15 per share (including 0.3 million shares at an average price of $71.68 in January 2018). Following the completion of the July 2015 share repurchase program, the Board of Directors authorized a new $1.0 billion share repurchase program in January 2018 that it expanded to $2.0 billion in May 2018 (as expanded, the “January 2018 share repurchase program”). During the nine and three months ended September 30, 2018, Altria repurchased 21.5 million shares and 6.2 million shares, respectively, of its common stock (at an aggregate cost of approximately $1,299 million and $367 million , respectively, and at an average price of $60.40 per share and $59.18 per share, respectively) under the January 2018 share repurchase program. At September 30, 2018, Altria had approximately $700 million remaining in the January 2018 share repurchase program. The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of the Board of Directors. Altria’s share repurchase activity was as follows: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions, except per share data) Total number of shares repurchased 21.8 33.2 6.2 11.1 Aggregate cost of shares repurchased $ 1,317 $ 2,359 $ 367 $ 759 Average price per share of shares repurchased $ 60.53 $ 70.97 $ 59.18 $ 67.99 Basis of Presentation The interim condensed consolidated financial statements of Altria are unaudited. It is the opinion of Altria’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected in the interim condensed consolidated financial statements. All such adjustments were of a normal recurring nature. Net revenues and net earnings for any interim period are not necessarily indicative of results that may be expected for the entire year. These statements should be read in conjunction with the consolidated financial statements and related notes, which appear in Altria’s Annual Report on Form 10-K for the year ended December 31, 2017 . On January 1, 2018, Altria adopted the following Accounting Standards Updates (“ASU”): ▪ ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) and all related ASU amendments (collectively “ASU No. 2014-09”); ▪ ASU No. 2016-01, Financial Instruments-Overall (Subtopic 825-10) : Recognition and Measurement of Financial Assets and Financial Liabilities and the related ASU amendment (collectively “ASU No. 2016-01”); ▪ ASU No. 2016-15, Statement of Cash Flows (Topic 230) : Classification of Certain Cash Receipts and Cash Payments (“ASU No. 2016-15”); ▪ ASU No. 2016-18, Statement of Cash Flows (Topic 230) : Restricted Cash (“ASU No. 2016-18”); and ▪ ASU No. 2017-07, Compensation-Retirement Benefits (Topic 715) : Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (“ASU No. 2017-07”). Altria has reclassified certain prior-period amounts to conform with the current period’s presentation due to Altria’s adoptions of ASU No. 2016-18 and ASU No. 2017-07. ASU No. 2014-09 establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. Altria has elected to apply the guidance using the modified retrospective transition method. For further discussion, see Note 2 . Revenues from Contracts with Customers . ASU No. 2016-01 addresses certain aspects of the recognition, measurement, presentation and disclosure of financial instruments. The adoption of ASU No. 2016-01 did not impact Altria’s condensed consolidated financial statements. ASU No. 2016-15 addresses how eight specific cash flow issues are to be presented and classified in the statement of cash flows. The adoption of ASU 2016-15 did not impact Altria’s condensed consolidated statements of cash flows. In addition, Altria made an accounting policy election to continue to classify distributions received from equity method investees using the nature of distribution approach. ASU No. 2016-18, which Altria adopted retrospectively, requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash and restricted cash equivalents. As a result of the adoption, restricted cash of $99 million , $61 million , $61 million and $82 million at September 30, 2018, September 30, 2017, December 31, 2017 and December 31, 2016, respectively, was included in cash, cash equivalents and restricted cash on the condensed consolidated statements of cash flows. ASU No. 2017-07 requires an employer to report the service cost component of net periodic pension cost and net periodic postretirement benefit cost in the same line item or items as other compensation costs arising from services rendered by employees during the period. The other components of net periodic pension cost and net periodic postretirement benefit cost are required to be presented in the statement of earnings separately from the service cost component and outside the subtotal of operating income. Additionally, only the service cost component is eligible for capitalization. Altria retrospectively adopted the guidance for the presentation of the service cost component and the other components of net periodic pension cost and net periodic postretirement benefit cost in the statement of earnings, and prospectively adopted the capitalization of service cost. Altria used the practical expedient provided in ASU No. 2017-07 that permits Altria to use the amounts disclosed in its benefit plans note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements. For the nine months ended September 30, 2017, the adoption of ASU No. 2017-07 resulted in a reclassification of net periodic benefit income of $20 million and $17 million from cost of sales and marketing, administration and research costs, respectively, to net periodic benefit income, excluding service cost in Altria’s condensed consolidated statement of earnings. For the three months ended September 30, 2017, the adoption of ASU No. 2017-07 resulted in a reclassification of net periodic benefit income of $12 million and $6 million from cost of sales and marketing, administration and research costs, respectively, to net periodic benefit income, excluding service cost in Altria’s condensed consolidated statement of earnings. In addition, certain prior-period segment data has been reclassified to conform with the current period’s presentation. For further discussion, see Note 7 . Segment Reporting . For a description of recently issued accounting guidance applicable to, but not yet adopted by, Altria, see Note 12 . Recent Accounting Guidance Not Yet Adopted .

Revenues from Contracts with Cu

Revenues from Contracts with Customers	9 Months Ended
	Sep. 30, 2018
Revenue from Contract with Customer [Abstract]
Revenues from Contracts with Customers	Revenues from Contracts with Customers: On January 1, 2018, Altria adopted ASU No. 2014-09, which establishes principles for reporting information about the nature, amount, timing, and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. Altria elected to apply the guidance using the modified retrospective transition method. The adoption of this guidance had no impact on the amount and timing of revenue recognized by Altria’s businesses; therefore, no adjustments were recorded to Altria’s condensed consolidated financial statements. Altria’s businesses generate substantially all of their revenue from sales contracts with customers. While Altria’s businesses enter into separate sales contracts with each customer for each product type, all sales contracts are similarly structured. These contracts create an obligation to transfer product to the customer. Contract durations do not exceed one year ; therefore, there is no significant financing component, costs to obtain contracts are expensed as incurred and unsatisfied performance obligations are not disclosed. Altria’s businesses define net revenues as revenues, which include excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns (also referred to as returned goods) and sales incentives. Altria’s businesses exclude from the transaction price, sales taxes and value-added taxes imposed at the time of sale (which do not include excise taxes on cigarettes, cigars, smokeless tobacco or wine). Altria’s businesses recognize revenues from sales contracts with customers upon shipment of goods when control of such products is obtained by the customer. Altria’s businesses determine that a customer obtains control of the product upon shipment when title of such product and risk of loss transfers to the customer. Altria’s businesses account for shipping and handling costs as fulfillment costs and such amounts are classified as part of cost of sales in Altria’s condensed consolidated statements of earnings. Altria’s businesses record an allowance for returned goods, based principally on historical volume and return rates, which is included in other accrued liabilities on Altria’s condensed consolidated balance sheets. Altria’s businesses record sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction to revenues (a portion of which is based on amounts estimated as being due to wholesalers, retailers and consumers at the end of a period) based principally on historical volume, utilization and redemption rates. Expected payments for sales incentives are included in accrued marketing liabilities on Altria’s condensed consolidated balance sheets. Payment terms vary depending on product type. Altria’s businesses consider payments received in advance of product shipment as deferred revenue, which is included in other accrued liabilities on Altria’s condensed consolidated balance sheets until revenue is recognized. PM USA receives payment in advance of a customer obtaining control of the product. USSTC receives substantially all payments within one business day of the customer obtaining control of the product. Ste. Michelle receives substantially all payments from customers within 45 days of the customer obtaining control of the product. Amounts due from customers are included in receivables on Altria’s condensed consolidated balance sheets. Altria’s businesses promote their products with consumer incentives, trade promotions and consumer engagement programs. These consumer incentive and trade promotion activities, which include discounts, coupons, rebates, in-store display incentives and volume-based incentives, do not create a distinct deliverable and are, therefore, recorded as a reduction of revenues. Consumer engagement program payments are made to third parties. Altria’s businesses expense these consumer engagement programs, which include event marketing, as incurred and such expenses are included in marketing, administration and research costs on Altria’s condensed consolidated statements of earnings. For interim reporting purposes, Altria’s businesses charge consumer engagement programs and certain consumer incentive expenses to operations as a percentage of sales, based on estimated sales and related expenses for the full year. Altria disaggregates net revenues based on product type. For further discussion, see Note 7 . Segment Reporting . Altria’s businesses offer cash discounts to customers for prompt payment and calculate cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. Altria’s businesses record an allowance for cash discounts, which is included as a contra-asset against receivables on Altria’s condensed consolidated balance sheets. There was no allowance for cash discounts at September 30, 2018 and December 31, 2017 , and there were no differences between amounts recorded as an allowance for cash discounts and cash discounts subsequently given to customers. Altria’s businesses that receive payments in advance of product shipment record such payments as deferred revenue. These payments are included in other accrued liabilities on Altria’s condensed consolidated balance sheets until control of such products is obtained by the customer. Deferred revenue was $116 million and $267 million at September 30, 2018 and December 31, 2017 , respectively. When cash is received in advance of product shipment, Altria’s businesses satisfy their performance obligations within three days of receiving payment. At September 30, 2018 and December 31, 2017, there were no differences between amounts recorded as deferred revenue and amounts subsequently recognized as revenue. Receivables, which primarily reflect sales of wine produced and/or distributed by Ste. Michelle, were $187 million and $142 million at September 30, 2018 and December 31, 2017 , respectively. At September 30, 2018 and December 31, 2017, there were no expected differences between amounts recorded and subsequently received, and Altria’s businesses did not record an allowance for doubtful accounts against these receivables. Altria’s businesses record an allowance for returned goods, which is included in other accrued liabilities on Altria’s condensed consolidated balance sheets. While all of Altria’s tobacco operating companies sell tobacco products with dates relative to freshness as printed on product packaging, due to the limited shelf life of USSTC’s smokeless tobacco products, it is USSTC’s policy to accept authorized sales returns from its customers for products that have passed such dates. Altria’s businesses record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues. Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions. Altria’s businesses reflect differences between actual and estimated sales returns in the period in which the actual amounts become known. These differences, if any, have not had a significant impact on Altria’s condensed consolidated financial statements. All returned goods are destroyed upon return and not included in inventory. Consequently, Altria’s businesses do not record an asset for their right to recover goods from customers upon return. Sales incentives include variable payments related to goods sold by Altria’s businesses. Altria’s businesses include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers. The sales incentives that require significant estimates and judgments are as follows: Price promotion payments- Altria’s businesses make price promotion payments, substantially all of which are made to their retail partners to incent the promotion of certain product offerings in select geographic areas. Wholesale and retail participation payments- Altria’s businesses make payments to their wholesale and retail partners to incent merchandising and sharing of sales data in accordance with each business’s trade agreements. These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates. Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions. Differences between actual and estimated payments are reflected in the period such information becomes available. These differences, if any, have not had a significant impact on Altria’s condensed consolidated financial statements.

Investment in AB InBev

Investment in AB InBev	9 Months Ended
	Sep. 30, 2018
Business Combinations [Abstract]
Investment in AB InBev	Investment in AB InBev: At September 30, 2018, Altria had an approximate 10.1% ownership of AB InBev, consisting of approximately 185 million restricted shares of AB InBev (the “Restricted Shares”) and approximately 12 million ordinary shares of AB InBev. Altria accounts for its investment in AB InBev under the equity method of accounting because Altria has the ability to exercise significant influence over the operating and financial policies of AB InBev, including having active representation on AB InBev’s Board of Directors (“AB InBev Board”) and certain AB InBev Board Committees. Through this representation, Altria participates in AB InBev policy making processes. Altria reviews its investment in AB InBev for impairment by comparing the fair value of its investment to its carrying value. If the carrying value of its investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and impairment is recognized in the period identified. The factors used to make this determination include the duration and magnitude of the fair value decline, AB InBev’s financial condition and near-term prospects, and Altria’s intent and ability to hold its investment in AB InBev until recovery. The fair value of Altria’s equity investment in AB InBev is based on: (i) unadjusted quoted prices in active markets for AB InBev’s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy. Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares. In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares. Therefore, the fair value of each Restricted Share is based on the value of an ordinary share. The fair value of Altria’s equity investment in AB InBev at September 30, 2018 and December 31, 2017 was $17.2 billion and $22.1 billion , respectively, compared with its carrying value of $17.8 billion and $18.0 billion , respectively. The fair value of Altria’s equity investment has continued to decline after September 30, 2018. On October 25, 2018, AB InBev announced a 50% rebase in the dividends it pays to its shareholders, which will result in a reduction of cash dividends AB InBev shareholders receive. The fair value of Altria’s equity investment at October 25, 2018 was approximately $14.5 billion . Based on its evaluation of the factors identified above, Altria concluded that the decline in fair value of its investment in AB InBev below its carrying value is temporary and, therefore, no impairment was recorded.

Benefit Plans

Benefit Plans	9 Months Ended
	Sep. 30, 2018
Retirement Benefits [Abstract]
Benefit Plans	Benefit Plans: Components of Net Periodic Benefit Cost (Income) Net periodic benefit cost (income) consisted of the following: For the Nine Months Ended September 30, For the Three Months Ended September 30, Pension Postretirement Pension Postretirement 2018 2017 2018 2017 2018 2017 2018 2017 (in millions) Service cost $ 61 $ 57 $ 13 $ 12 $ 20 $ 19 $ 4 $ 3 Interest cost 207 216 52 57 69 72 15 17 Expected return on plan assets (438 ) (451 ) (14 ) — (146 ) (151 ) (5 ) — Amortization: Net loss 168 147 16 19 56 49 (1 ) 3 Prior service cost (credit) 3 3 (31 ) (28 ) 1 1 (10 ) (9 ) Net periodic benefit cost (income) $ 1 $ (28 ) $ 36 $ 60 $ — $ (10 ) $ 3 $ 14 Employer Contributions Altria makes contributions to the pension plans to the extent that the contributions are tax deductible and pays benefits that relate to plans for salaried employees that cannot be funded under Internal Revenue Service (“IRS”) regulations. Altria made employer contributions of $19 million to its pension plans during the nine months ended September 30, 2018 . Currently, Altria anticipates making additional employer contributions to its pension plans during the remainder of 2018 of up to approximately $ 25 million , based on current tax law. Altria did not make any employer contributions to its postretirement plans during the nine months ended September 30, 2018 . Currently, Altria anticipates making employer contributions to its postretirement plans of up to approximately $ 70 million in 2018. However, estimates for current-year contributions to Altria’s pension and postretirement plans may be subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on assets, changes in interest rates or other considerations.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2018
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share: Basic and diluted earnings per share (“EPS”) were calculated using the following: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Net earnings attributable to Altria $ 5,713 $ 5,256 $ 1,943 $ 1,866 Less: Distributed and undistributed earnings attributable to share-based awards (7 ) (7 ) (2 ) (2 ) Earnings for basic and diluted EPS $ 5,706 $ 5,249 $ 1,941 $ 1,864 Weighted-average shares for basic and diluted EPS 1,891 1,927 1,883 1,915

Other Comprehensive Earnings_Lo

Other Comprehensive Earnings/Losses	9 Months Ended
	Sep. 30, 2018
Equity [Abstract]
Other Comprehensive Earnings/Losses	Other Comprehensive Earnings/Losses: The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria: For the Nine Months Ended September 30, 2018 Benefit Plans AB InBev Currency Translation Adjustments and Other Accumulated Other Comprehensive Losses (in millions) Balances, December 31, 2017 $ (1,839 ) $ (54 ) $ (4 ) $ (1,897 ) Other comprehensive losses before reclassifications — (288 ) (1 ) (289 ) Deferred income taxes — 57 — 57 Other comprehensive losses before reclassifications, net of deferred income taxes — (231 ) (1 ) (232 ) Amounts reclassified to net earnings 168 (41 ) — 127 Deferred income taxes (42 ) 10 — (32 ) Amounts reclassified to net earnings, net of deferred income taxes 126 (31 ) — 95 Other comprehensive earnings (losses), net of deferred income taxes 126 (262 ) (1 ) (1 ) (137 ) Balances, September 30, 2018 $ (1,713 ) $ (316 ) $ (5 ) $ (2,034 ) For the Three Months Ended September 30, 2018 Benefit Plans AB InBev Currency Translation Adjustments and Other Accumulated Other Comprehensive Losses (in millions) Balances, June 30, 2018 $ (1,752 ) $ 106 $ (6 ) $ (1,652 ) Other comprehensive (losses) earnings before reclassifications — (513 ) 1 (512 ) Deferred income taxes — 107 — 107 Other comprehensive (losses) earnings before reclassifications, net of deferred income taxes — (406 ) 1 (405 ) Amounts reclassified to net earnings 50 (21 ) — 29 Deferred income taxes (11 ) 5 — (6 ) Amounts reclassified to net earnings, net of deferred income taxes 39 (16 ) — 23 Other comprehensive earnings (losses), net of deferred income taxes 39 (422 ) (1 ) 1 (382 ) Balances, September 30, 2018 $ (1,713 ) $ (316 ) $ (5 ) $ (2,034 ) For the Nine Months Ended September 30, 2017 Benefit Plans AB InBev Currency Translation Adjustments and Other Accumulated Other Comprehensive Losses (in millions) Balances, December 31, 2016 $ (2,048 ) $ — $ (4 ) $ (2,052 ) Other comprehensive earnings before reclassifications — 9 1 10 Deferred income taxes — (3 ) — (3 ) Other comprehensive earnings before reclassifications, net of deferred income taxes — 6 1 7 Amounts reclassified to net earnings 154 5 — 159 Deferred income taxes (58 ) (2 ) — (60 ) Amounts reclassified to net earnings, net of deferred income taxes 96 3 — 99 Other comprehensive earnings, net of deferred income taxes 96 9 (1 ) 1 106 Balances, September 30, 2017 $ (1,952 ) $ 9 $ (3 ) $ (1,946 ) For the Three Months Ended September 30, 2017 Benefit Plans AB InBev Currency Translation Adjustments and Other Accumulated Other Comprehensive Losses (in millions) Balances, June 30, 2017 $ (1,983 ) $ 148 $ (3 ) $ (1,838 ) Other comprehensive losses before reclassifications — (216 ) — (216 ) Deferred income taxes — 75 — 75 Other comprehensive losses before reclassifications, net of deferred income taxes — (141 ) — (141 ) Amounts reclassified to net earnings 48 3 — 51 Deferred income taxes (17 ) (1 ) — (18 ) Amounts reclassified to net earnings, net of deferred income taxes 31 2 — 33 Other comprehensive earnings (losses), net of deferred income taxes 31 (139 ) (1 ) — (108 ) Balances, September 30, 2017 $ (1,952 ) $ 9 $ (3 ) $ (1,946 ) (1) Primarily reflects currency translation adjustments. The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Benefit Plans: (1) Net loss $ 196 $ 179 $ 59 $ 56 Prior service cost/credit (28 ) (25 ) (9 ) (8 ) 168 154 50 48 AB InBev (2) (41 ) 5 (21 ) 3 Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings $ 127 $ 159 $ 29 $ 51 (1) Amounts are included in net defined benefit plan costs. For further details, see Note 4 . Benefit Plans. (2) Amounts are primarily included in earnings from equity investment in AB InBev.

Segment Reporting

Segment Reporting	9 Months Ended
	Sep. 30, 2018
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting: The products of Altria’s subsidiaries include smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA and Nat Sherman, machine-made large cigars and pipe tobacco manufactured and sold by Middleton and premium cigars sold by Nat Sherman; smokeless tobacco products, consisting of moist smokeless tobacco and snus products manufactured and sold by USSTC; and wine produced and/or distributed by Ste. Michelle. The products and services of these subsidiaries constitute Altria’s reportable segments of smokeable products, smokeless products and wine. The financial services and the innovative tobacco products businesses are included in all other. As discussed in Note 1 . Background and Basis of Presentation , on January 1, 2018, Altria adopted ASU 2017-07, which resulted in a change to prior-period operating income. As a result, certain immaterial prior-period operating companies income (loss) data has been reclassified to conform with the current period’s presentation. Altria’s chief operating decision maker (the “CODM”) reviews operating companies income to evaluate the performance of, and allocate resources to, the segments. Operating companies income for the segments is defined as operating income before general corporate expenses and amortization of intangibles. Interest and other debt expense, net, net periodic benefit cost/income, excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by the CODM. Segment data were as follows: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Net revenues: Smokeable products $ 16,995 $ 17,355 $ 6,035 $ 5,975 Smokeless products 1,690 1,580 586 550 Wine 489 471 181 181 All other 76 69 35 23 Net revenues $ 19,250 $ 19,475 $ 6,837 $ 6,729 Earnings before income taxes: Operating companies income (loss): Smokeable products $ 6,516 $ 6,536 $ 2,277 $ 2,276 Smokeless products 1,085 941 370 348 Wine 73 82 29 36 All other (121 ) (31 ) (38 ) (10 ) Amortization of intangibles (30 ) (15 ) (20 ) (5 ) General corporate expenses (152 ) (157 ) (61 ) (56 ) Operating income 7,371 7,356 2,557 2,589 Interest and other debt expense, net (503 ) (525 ) (159 ) (169 ) Net periodic benefit income, excluding service cost 37 37 21 18 Earnings from equity investment in AB InBev 759 332 189 169 (Loss) gain on AB InBev/SABMiller business combination (33 ) 445 — 37 Earnings before income taxes $ 7,631 $ 7,645 $ 2,608 $ 2,644 The comparability of operating companies income for the reportable segments was affected by the following: Non-Participating Manufacturer (“NPM”) Adjustment Items - Pre-tax (income) expense for NPM adjustment items was recorded in Altria’s condensed consolidated statements of earnings as follows: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Smokeable products segment $ (145 ) $ (5 ) $ — $ 3 Interest and other debt expense, net — 9 — 2 Total $ (145 ) $ 4 $ — $ 5 NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the 1998 Master Settlement Agreement (such dispute resolutions are referred to as “NPM Adjustment Items” and are more fully described in Health Care Cost Recovery Litigation - NPM Adjustment Disputes in Note 10 . Contingencies ) . The amounts shown in the table above for the smokeable products segment were recorded by PM USA as (reductions) increases to cost of sales, which (increased) decreased operating companies income in the smokeable products segment. Tobacco and Health Litigation Items - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria’s condensed consolidated statements of earnings as follows: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Smokeable products segment $ 94 $ 16 $ 10 $ — Smokeless products segment 10 — 10 — Interest and other debt expense, net 15 2 1 — Total $ 119 $ 18 $ 21 $ — The amounts shown in the table above for the smokeable and smokeless products segments were recorded in marketing, administration and research costs. For further discussion, see Note 10 . Contingencies . Smokeless Products Recall - During the first quarter of 2017, USSTC voluntarily recalled certain smokeless tobacco products manufactured at its Franklin Park, Illinois facility due to a product tampering incident (the “Recall”). USSTC estimated that the Recall reduced smokeless products segment operating companies income by approximately $60 million in the first quarter of 2017. Asset Impairment, Exit and Implementation Costs - In October 2016, Altria announced the consolidation of certain of its operating companies’ manufacturing facilities to streamline operations and achieve greater efficiencies. In the first quarter of 2018, Middleton completed the transfer of its Limerick, Pennsylvania operations to the Manufacturing Center site in Richmond, Virginia (“Richmond Manufacturing Center”), and USSTC completed the transfer of its Franklin Park, Illinois operations to its Nashville, Tennessee facility and the Richmond Manufacturing Center. The pre-tax charges related to the consolidation are complete. Pre-tax asset impairment, exit and implementation costs recorded in connection with the facilities consolidation consisted of the following: For the Nine Months Ended September 30, 2018 For the Nine Months Ended September 30, 2017 Asset Impairment and Exit Costs Implementation Costs (1) Total Asset Impairment and Exit Costs Implementation Costs (1) Total (in millions) Smokeable products $ (4 ) $ 1 $ (3 ) $ 2 $ 17 $ 19 Smokeless products 6 3 9 22 30 52 Total $ 2 $ 4 $ 6 $ 24 $ 47 $ 71 For the Three Months Ended September 30, 2018 For the Three Months Ended September 30, 2017 Asset Impairment and Exit Costs Implementation Costs (1) Total Asset Impairment and Exit Costs Implementation Costs (1) Total (in millions) Smokeable products $ (5 ) $ (1 ) $ (6 ) $ — $ 5 $ 5 Smokeless products 3 — 3 8 2 10 Total $ (2 ) $ (1 ) $ (3 ) $ 8 $ 7 $ 15 (1) The pre-tax implementation costs were included in cost of sales in Altria’s condensed consolidated statements of earnings.

Debt

Debt	9 Months Ended
	Sep. 30, 2018
Debt Disclosure [Abstract]
Debt	Debt: Short-term Borrowings and Borrowing Arrangements At September 30, 2018 and December 31, 2017 , Altria had no short-term borrowings. On August 1, 2018, Altria entered into a senior unsecured 5 -year revolving credit agreement (the “Credit Agreement”). The Credit Agreement, which is used for general corporate purposes, provides for borrowings up to an aggregate principal amount of $3.0 billion . The Credit Agreement expires on August 1, 2023 and includes an option, subject to certain conditions, for Altria to extend the Credit Agreement for two additional one -year periods. The Credit Agreement replaced Altria’s prior $3.0 billion senior unsecured 5 -year revolving credit agreement, which was to expire on August 19, 2020 and was terminated effective August 1, 2018. Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of Altria’s long-term senior unsecured debt. Interest rates on borrowings under the Credit Agreement are expected to be based on the London Interbank Offered Rate (“LIBOR”) plus a percentage based on the higher of the ratings of Altria’s long-term senior unsecured debt from Moody’s Investors Service, Inc. and Standard & Poor’s Ratings Services. The applicable percentage based on Altria’s long-term senior unsecured debt ratings at September 30, 2018 for borrowings under the Credit Agreement was 1.0% . The Credit Agreement does not include any other rating triggers, or any provisions that could require the posting of collateral. At September 30, 2018, credit available to Altria under the Credit Agreement was $3.0 billion . The Credit Agreement includes various covenants, one of which requires Altria to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (“EBITDA”) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis. At September 30, 2018, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 14.8 to 1.0. At September 30, 2018, Altria was in compliance with, and expects to continue to meet, its covenants associated with the Credit Agreement. The terms “Consolidated EBITDA” and “Consolidated Interest Expense,” each as defined in the Credit Agreement, include certain adjustments. Any commercial paper issued by Altria and borrowings under the Credit Agreement are guaranteed by PM USA as further discussed in Note 11 . Condensed Consolidating Financial Information. Long-term Debt Altria’s estimate of the fair value of its debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy. The aggregate fair value of Altria’s total long-term debt at September 30, 2018 and December 31, 2017 , was $14.2 billion and $15.3 billion , respectively, as compared with its carrying value of $13.9 billion for each period. At September 30, 2018 and December 31, 2017, accrued interest on long-term debt of $155 million and $219 million , respectively, was included in other accrued liabilities on Altria’s condensed consolidated balance sheets.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2018
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes: On December 22, 2017, the U.S. Government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Reform Act”). The main provisions of the Tax Reform Act that impact Altria include: (i) a reduction in the U.S. federal statutory corporate income tax rate from 35% to 21% effective January 1, 2018, and (ii) changes in the treatment of foreign-source income, commonly referred to as a modified territorial tax system. The transition to a modified territorial tax system required Altria to record a deemed repatriation tax and an associated tax basis benefit in 2017. Substantially all of the deemed repatriation tax was related to Altria’s share of AB InBev’s accumulated earnings. Dividends received from AB InBev beginning in 2017, to the extent that such dividends represent previously taxed income attributable to the deemed repatriation tax, result in an associated tax basis expense, which reverses the tax basis benefit recorded in 2017. The Tax Reform Act also includes a provision to tax global intangible low-taxed income (“GILTI”) of foreign subsidiaries. Altria made an accounting policy election to treat taxes due under the GILTI provision as a current period expense. The income tax rate of 25.1% for the nine months ended September 30, 2018 decreased 6.1 percentage points from the nine months ended September 30, 2017. This decrease was due primarily to the following: ▪ a reduction in tax expense in 2018 from the decrease in the U.S. federal statutory corporate income tax rate as a result of the Tax Reform Act; and ▪ tax expense of $114 million in 2017 for tax reserves related to the calculation of certain foreign tax credits; partially offset by: ▪ tax benefits of $232 million in 2017 for the release of a valuation allowance related to deferred income tax assets for foreign tax credit carryforwards; ▪ tax benefits of $152 million in 2017 related primarily to the effective settlement of the IRS audit of Altria and its consolidated subsidiaries’ 2010-2013 tax years; ▪ tax expense of $122 million in 2018, resulting from a partial reversal of the tax basis benefit associated with the deemed repatriation tax; ▪ tax expense of $51 million in 2018 for a valuation allowance on foreign tax credit carryforwards that are not realizable as a result of updates to the provisional estimates recorded in 2017 for the Tax Reform Act; and ▪ tax benefits of $36 million in 2017 for the reversal of tax accruals no longer required. The income tax rate of 25.5% for the three months ended September 30, 2018 decreased 3.9 percentage points from the three months ended September 30, 2017. This decrease was due primarily to the following: ▪ a reduction in tax expense in 2018 from the decrease in the U.S. federal statutory corporate income tax rate as a result of the Tax Reform Act; and ▪ tax expense of $114 million in 2017 for tax reserves related to the calculation of certain foreign tax credits; partially offset by: ▪ tax benefits of $232 million in 2017 for the release of a valuation allowance related to deferred income tax assets for foreign tax credit carryforwards; ▪ tax expense of $40 million in 2018, resulting from a partial reversal of the tax basis benefit associated with the deemed repatriation tax; ▪ tax benefits of $36 million in 2017 for the reversal of tax accruals no longer required; and ▪ tax expense of $17 million in 2018 for a valuation allowance on foreign tax credit carryforwards that are not realizable as a result of updates to the provisional estimates recorded in 2017 for the Tax Reform Act. During the nine and three months ended September 30, 2018, Altria recorded net tax expense of $1 million and a tax benefit of $1 million , respectively, as adjustments to the provisional estimates recorded in 2017 for the tax basis adjustment and the deemed repatriation tax attributable to the Tax Reform Act. Altria may be required to adjust these provisional estimates based on (i) additional guidance related to, or interpretation of, the Tax Reform Act and associated tax laws and (ii) additional information to be received from AB InBev, including information regarding AB InBev’s accumulated earnings and associated taxes for the 2016 and 2017 tax years. This additional guidance and information could result in increases or decreases to the provisional estimates, which may be significant in relation to these estimates. Altria will record any such adjustments in 2018. Altria is subject to income taxation in many jurisdictions. Uncertain tax positions reflect the difference between tax positions taken or expected to be taken on income tax returns and the amounts recognized in the financial statements. Resolution of the related tax positions with the relevant tax authorities may take many years to complete, and such timing is not entirely within the control of Altria. At September 30, 2018 , Altria’s total unrecognized tax benefits were $(34) million . The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at September 30, 2018 was $58 million , along with $(92) million affecting deferred taxes. It is reasonably possible that within the next 12 months certain examinations will be resolved, which could result in a change to Altria’s total unrecognized tax benefits to approximately $(75) million . At December 31, 2017, Altria’s total unrecognized tax benefits were $66 million . The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December 31, 2017 was $43 million , along with $23 million affecting deferred taxes.

Contingencies

Contingencies	9 Months Ended
	Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies: Legal proceedings covering a wide range of matters are pending or threatened in various United States and foreign jurisdictions against Altria and its subsidiaries, including PM USA and UST and its subsidiaries, as well as their respective indemnitees. Various types of claims may be raised in these proceedings, including product liability, consumer protection, antitrust, tax, contraband shipments, patent infringement, employment matters, claims for contribution and claims of competitors, shareholders or distributors. Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases. An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation. Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. In certain cases, plaintiffs claim that defendants’ liability is joint and several. In such cases, Altria or its subsidiaries may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment. As a result, Altria or its subsidiaries under certain circumstances may have to pay more than their proportionate share of any bonding- or judgment-related amounts. Furthermore, in those cases where plaintiffs are successful, Altria or its subsidiaries may also be required to pay interest and attorneys’ fees. Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases. This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all. As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida’s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well. Such challenges may include the applicability of state bond caps in federal court. States, including Florida, may also seek to repeal or alter bond cap statutes through legislation. Although Altria cannot predict the outcome of such challenges, it is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges. Altria and its subsidiaries record provisions in the condensed consolidated financial statements for pending litigation when they determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 10 . Contingencies : (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending tobacco-related cases; and (iii) accordingly, management has not provided any amounts in the condensed consolidated financial statements for unfavorable outcomes, if any. Litigation defense costs are expensed as incurred. Altria and its subsidiaries have achieved substantial success in managing litigation. Nevertheless, litigation is subject to uncertainty and significant challenges remain. It is possible that the consolidated results of operations, cash flows or financial position of Altria, or one or more of its subsidiaries, could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Altria and each of its subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts. Each of the companies has defended, and will continue to defend, vigorously against litigation challenges. However, Altria and its subsidiaries may enter into settlement discussions in particular cases if they believe it is in the best interests of Altria to do so. Overview of Altria and/or PM USA Tobacco-Related Litigation Types and Number of Cases Claims related to tobacco products generally fall within the following categories: (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including cases in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding; (iii) health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iv) class action suits alleging that the uses of the terms “Lights” and “Ultra Lights” constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of the Racketeer Influenced and Corrupt Organizations Act (“RICO”); and (v) other tobacco-related litigation described below. Plaintiffs’ theories of recovery and the defenses raised in pending smoking and health, health care cost recovery and “Lights/Ultra Lights” cases are discussed below. The table below lists the number of certain tobacco-related cases pending in the United States against PM USA and, in some instances, Altria as of October 22, 2018, October 23, 2017 and October 24, 2016: October 22, 2018 October 23, 2017 October 24, 2016 Individual Smoking and Health Cases (1) 101 87 66 Smoking and Health Class Actions and Aggregated Claims Litigation (2) 2 4 5 Health Care Cost Recovery Actions (3) 1 1 1 “Lights/Ultra Lights” Class Actions 2 4 9 (1) Includes 29 cases filed in Massachusetts and 38 non- Engle cases filed in Florida. Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the Engle case (these Engle progeny cases are discussed below in Smoking and Health Litigation - Engle Class Action ). Also does not include 1,491 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (“ETS”). The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 ( Broin ). The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. In March 2018, 923 of these cases were voluntarily dismissed without prejudice. (2) The 2016 and 2017 pending cases include as one case the 30 civil actions that were to be tried in six consolidated trials in West Virginia ( In re: Tobacco Litigation ). PM USA was a defendant in nine of the 30 cases. The parties resolved these cases for an immaterial amount and in the second quarter of 2018, the court dismissed all 30 cases. (3) See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below. International Tobacco-Related Cases As of October 22, 2018, PM USA is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant. PM USA and Altria are also named defendants in seven smoking and health class actions filed in various Canadian provinces. See Guarantees and Other Similar Matters below for a discussion of the Distribution Agreement between Altria and Philip Morris International Inc. (“PMI”) that provides for indemnities for certain liabilities concerning tobacco products. Tobacco-Related Cases Set for Trial As of October 22, 2018, 5 Engle progeny cases are set for trial through December 31, 2018. In addition, there are two individual smoking and health case against PM USA set for trial during this period. Cases against other companies in the tobacco industry may also be scheduled for trial during this period. Trial dates are subject to change. Trial Results Since January 1999, excluding the Engle progeny cases (separately discussed below), verdicts have been returned in 64 smoking and health, “Lights/Ultra Lights” and health care cost recovery cases in which PM USA was a defendant. Verdicts in favor of PM USA and other defendants were returned in 43 of the 64 cases. These 43 cases were tried in Alaska ( 1 ), California ( 7 ), Connecticut ( 1 ), Florida ( 10 ), Louisiana ( 1 ), Massachusetts ( 3 ), Mississippi ( 1 ), Missouri ( 4 ), New Hampshire ( 1 ), New Jersey ( 1 ), New York ( 5 ), Ohio ( 2 ), Pennsylvania ( 1 ), Rhode Island ( 1 ), Tennessee ( 2 ) and West Virginia ( 2 ). A motion for a new trial was granted in one of the cases in Florida and in the case in Alaska. In the Alaska case ( Hunter ), the jury returned a verdict in favor of PM USA in April 2018 in the third trial of this case. In May 2018, plaintiff filed a motion for a new trial, which the court denied. Of the 21 non- Engle progeny cases in which verdicts were returned in favor of plaintiffs, 19 have reached final resolution. See Smoking and Health Litigation - Engle Progeny Trial Results below for a discussion of verdicts in state and federal Engle progeny cases involving PM USA as of October 22, 2018. Judgments Paid and Provisions for Tobacco and Health Litigation Items (Including Engle Progeny Litigation) After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid in the aggregate judgments and settlements (including related costs and fees) totaling approximately $578 million and interest totaling approximately $195 million as of September 30, 2018. These amounts include payments for Engle progeny judgments (and related costs and fees) totaling approximately $186 million , interest totaling approximately $33 million and payment of approximately $43 million in connection with the Federal Engle Agreement, discussed below. The changes in Altria’s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Accrued liability for tobacco and health litigation items at beginning of period (1) $ 106 $ 47 $ 107 $ 47 Pre-tax charges for: Tobacco and health litigation 104 16 20 — Related interest costs 15 2 1 — Payments (1) (118 ) (18 ) (21 ) — Accrued liability for tobacco and health litigation items at end of period (1) $ 107 $ 47 $ 107 $ 47 (1) Includes amounts related to the costs of implementing the corrective communications remedy related to the Federal Government’s Lawsuit discussed below. The accrued liability for tobacco and health litigation items, including related interest costs, was included in liabilities on Altria’s condensed consolidated balance sheets. Pre-tax charges for tobacco and health litigation were included in marketing, administration and research costs on Altria’s condensed consolidated statements of earnings. Pre-tax charges for related interest costs were included in interest and other debt expense, net on Altria’s condensed consolidated statements of earnings. Security for Judgments To obtain stays of judgments pending appeal, PM USA has posted various forms of security. As of September 30, 2018 , PM USA has posted appeal bonds totaling approximately $99 million , which have been collateralized with cash deposits that are included in assets on the condensed consolidated balance sheet. Smoking and Health Litigation Overview Plaintiffs’ allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of deceptive trade practice laws and consumer protection statutes, and claims under the federal and state anti-racketeering statutes. Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act. Non-Engle Progeny Litigation Summarized below are the non- Engle progeny smoking and health cases pending during 2018 in which a verdict was returned in favor of plaintiff and against PM USA. Charts listing certain verdicts for plaintiffs in the Engle progeny cases can be found in Smoking and Health Litigation - Engle Progeny Trial Results below. Gentile : In October 2017, a jury in a Florida state court returned a verdict in favor of plaintiff, awarding approximately $7.1 million in compensatory damages and allocating 75% of the fault to PM USA (an amount of approximately $5.3 million ). In April 2018, the trial court entered final judgment in favor of plaintiff and PM USA posted a bond in the amount of approximately $8 million . In May 2018, PM USA filed a notice of appeal to the Florida Fourth District Court of Appeal. Bullock : In December 2015, a jury in the U.S. District Court for the Central District of California returned a verdict in favor of plaintiff, awarding $900,000 in compensatory damages. On appeal, the U.S. Court of Appeals for the Ninth Circuit affirmed the judgment. In the fourth quarter of 2017, PM USA recorded a provision on its consolidated balance sheet of approximately $1 million for the judgment, interest and associated costs. In the first quarter of 2018, PM USA paid this amount, concluding this litigation. Federal Government’s Lawsuit : See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below for a discussion of the verdict and post-trial developments in the United States of America health care cost recovery case. Engle Class Action In July 2000, in the second phase of the Engle smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA. Following entry of judgment, PM USA appealed. In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class. Plaintiffs petitioned the Florida Supreme Court for further review. In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate. The court further declared the following Phase I findings are entitled to res judicata effect in such individual actions brought within one year of the issuance of the mandate: (i) that smoking causes various diseases; (ii) that nicotine in cigarettes is addictive; (iii) that defendants’ cigarettes were defective and unreasonably dangerous; (iv) that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v) that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi) that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii) that all defendants sold or supplied cigarettes that were defective; and (viii) that defendants were negligent. The court also reinstated compensatory damages awards totaling approximately $6.9 million to two individual plaintiffs and found that a third plaintiff’s claim was barred by the statute of limitations. In February 2008 , PM USA paid approximately $3 million , representing its share of compensatory damages and interest, to the two individual plaintiffs identified in the Florida Supreme Court’s order. In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion. In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to res judicata effect by excluding finding (v) listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants. In January 2007, the Florida Supreme Court issued the mandate from its revised opinion. In May 2007, defendants filed a petition for writ of certiorari with the United States Supreme Court, which was denied. In February 2008, the trial court decertified the class. Engle Progeny Cases The deadline for filing Engle progeny cases expired in January 2008. As of October 22, 2018, approximately 2,200 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 3,000 state court plaintiffs. Because of a number of factors, including, but not limited to, docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates. While the Federal Engle Agreement (discussed below) resolved nearly all Engle progeny cases pending in federal court, as of October 22, 2018, approximately 7 cases were pending against PM USA in federal court representing the cases excluded from that agreement. Agreement to Resolve Federal Engle Progeny Cases In 2015, PM USA, R.J. Reynolds Tobacco Company (“R.J. Reynolds”) and Lorillard Tobacco Company (“Lorillard”) resolved approximately 415 pending federal Engle progeny cases (the “Federal Engle Agreement”). Under the terms of the Federal Engle Agreement, PM USA paid approximately $43 million . Federal cases that were in trial and those that previously reached final verdict were not included in the Federal Engle Agreement. Engle Progeny Trial Results As of October 22, 2018, 124 federal and state Engle progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court Engle decision. Sixty-eight verdicts were returned in favor of plaintiffs and eight verdicts ( Skolnick , Calloway , Pollari , McCoy , Duignan , Caprio, Oshinsky-Blacker and McCall ) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending. Skolnick was remanded for a new trial on plaintiff’s concealment and conspiracy claims; Calloway was reversed and remanded for a new trial on an appellate finding that improper arguments by plaintiff’s counsel deprived defendants of a fair trial; Pollari and McCoy were reversed and remanded for a new trial on an appellate finding that the trial court erred in admitting certain materials into evidence that deprived defendants of a fair trial; Duignan was reversed and remanded for a new trial on an appellate finding that the trial judge erred in responding to a question from the jury during deliberations; Caprio was reversed post-trial after defendants agreed to voluntarily dismiss their appeal in exchange for a full retrial; Oshinsky-Blacker was reversed post-trial based on plaintiff’s counsel’s improper arguments at trial; and McCall was reversed based on an appellate finding that the trial judge erred in instructing the jury on the warning labels on cigarette packs. Forty-four verdicts were returned in favor of PM USA, of which 37 were state cases. In addition, there have been a number of mistrials, only some of which have resulted in new trials as of October 22, 2018. Four verdicts ( D. Cohen , Collar, Chacon and Starbuck ) that were returned in favor of PM USA were subsequently reversed for new trials. Juries in two cases ( Reider and Banks ) returned zero damages verdicts in favor of PM USA . Juries in two other cases ( Weingart and Hancock ) returned verdicts against PM USA awarding no damages, but the trial court in each case granted an additur . The charts below list the verdicts and post-trial developments in certain Engle progeny cases in which verdicts were returned in favor of plaintiffs. The first chart lists such cases that are pending as of October 22, 2018; the second chart lists such cases that were pending within the previous 12 months, but that are now concluded. Unless otherwise noted for a particular case, the jury’s award for compensatory damages will not be reduced by any finding of plaintiff’s comparative fault (see Engle Progeny Appellate Issues below for a discussion of the Florida Supreme Court’s decision in Schoeff ). Currently-Pending Engle Cases ______________________________________________________________________________________________________ Plaintiff: Chadwell Date: September 2018 Verdict: A Miami-Dade County jury returned a verdict in favor of plaintiff and against PM USA awarding compensatory damages of $2.4 million . The jury did not award any punitive damages. Post-Trial Developments: In September 2018, the trial court entered final judgment in favor of plaintiff and, in October 2018, PM USA filed various post-trial motions, including motions for a new trial and to set aside the verdict. ______________________________________________________________________________________________________ Plaintiff: Kaplan Date: July 2018 Verdict: A Broward County jury returned a verdict in favor of plaintiff and against PM USA and R.J. Reynolds awarding compensatory damages of approximately $2.1 million . The jury also awarded $2.3 million in punitive damages against PM USA. Post-Trial Developments: In July 2018, the trial court entered final judgment in favor of plaintiff and defendants filed various post-trial motions, including motions for a new trial and to set aside the verdict. In August 2018, the trial court denied all post-trial motions. In September 2018, defendants filed a notice of appeal to the Florida Fourth District Court of Appeal and PM USA posted a bond in the amount of approximately $3 million . In October 2018, plaintiff cross-appealed. ______________________________________________________________________________________________________ Plaintiff: Landi Date: June 2018 Verdict: A Broward County jury returned a verdict in favor of plaintiff and against PM USA and R.J. Reynolds awarding compensatory damages of $8 million . The jury also awarded $5 million in punitive damages against PM USA. Post-Trial Developments: In June 2018, the trial court entered final judgment in favor of plaintiff and defendants filed various post-trial motions, including motions for a new trial and to set aside the verdict. In July 2018, the trial court denied all post-trial motions. In August 2018, defendants filed a notice of appeal to the Florida Fourth District Court of Appeal and PM USA posted a bond in the amount of approximately $2 million . In September 2018, plaintiff cross-appealed. ______________________________________________________________________________________________________ Plaintiff: Theis Date: May 2018 Verdict: A Sarasota County jury returned a verdict in favor of plaintiff and against PM USA and R.J. Reynolds awarding compensatory damages of $7 million . The jury also awarded $10 million in punitive damages against PM USA. Post-Trial Developments: In June 2018, the trial court entered final judgment in favor of plaintiff and defendants filed various post-trial motions, including motions to set aside various portions of the verdict and for a new trial or, in the alternative, for remittitur of the damages awards. In July 2018, the trial court denied all post-trial motions. In August 2018, defendants filed a notice of appeal to the Florida Second District Court of Appeal and PM USA posted a bond in the amount of approximately $3 million . ______________________________________________________________________________________________________ Plaintiff: Freeman Date: March 2018 Verdict: An Alachua County jury returned a verdict in favor of plaintiff and against PM USA awarding compensatory damages of $4 million . The jury did not award any punitive damages. Post-Trial Developments: In March 2018, the trial court entered final judgment in favor of plaintiff and PM USA filed various post-trial motions, including motions to enter judgment in defendant’s favor and for a new trial. In April 2018, the trial court denied all post-trial motions. In May 2018, PM USA filed a notice of appeal to the Florida First District Court of Appeal and posted a bond in the amount of $4 million . ______________________________________________________________________________________________________ Plaintiff: Gloger Date: February 2018 Verdict: A Miami-Dade County jury returned a verdict in favor of plaintiff and against PM USA and R.J. Reynolds awarding compensatory damages of $7.5 million . The jury also awarded $5 million in punitive damages against PM USA. Post-Trial Developments: In February 2018, the trial court entered final judgment in favor of plaintiff and defendants filed various post-trial motions, including motions to enter judgment in defendants’ favor and for a new trial, which the trial court denied in May 2018. Also in February 2018, defendants filed a notice of appeal to the Florida Third District Court of Appeal and posted a bond in the amount of approximately $3 million . ______________________________________________________________________________________________________ Plaintiff: Bryant Date: December 2017 Verdict: An Escambia County jury returned a verdict in favor of plaintiff and against PM USA awarding compensatory damages of $581,000 . The jury also awarded $225,000 in punitive damages against PM USA. Post-Trial Developments: In December 2017, PM USA filed various post-trial motions, including motions to enter judgment in its favor and for a new trial. Plaintiff also filed a motion for a new trial on the amount of punitive damages. In February 2018, the trial court denied all post-trial motions and entered final judgment in favor of plaintiff. In March 2018, PM USA filed a notice of appeal to the Florida First District Court of Appeal and posted a bond in the amount of approximately $1 million . ______________________________________________________________________________________________________ Plaintiff: R. Douglas Date: November 2017 Verdict: A Duval County jury returned a verdict in favor of plaintiff and against PM USA awarding compensatory damages of $131,371 and allocating 4% of the fault to PM USA (an amount of $5,255 ). Post-Trial Developments: In November 2017, PM USA filed a motion to set aside the verdict, and plaintiff filed a motion for a new trial or, in the alternative, for an additur of the damages award. In February 2018, the trial court denied the parties’ post-trial motions. ______________________________________________________________________________________________________ Plaintiff: Wallace Date: October 2017 Verdict: A Brevard County jury returned a verdict in favor of plaintiff and against PM USA and R.J. Reynolds awarding compensatory damages of $12 million . The jury also awarded plaintiff $16 million in punitive damages against PM USA. Post-Trial Developments: In November 2017, defendants filed post-trial motions, including for a new trial or remittitur of the damages awards. In December 2017, the court denied certain post-trial motions. In January 2018, the court denied the remaining post-trial motions and entered final judgment against PM USA and R.J. Reynolds. In February 2018, defendants filed a notice of appeal to the Florida Fifth District Court of Appeal and posted a bond in the amount of approximately $3 million , and plaintiff cross-appealed. ______________________________________________________________________________________________________ Plaintiff: L. Martin Date: May 2017 Verdict: A Miami-Dade County jury returned a verdict in favor of plaintiff and against PM USA awarding compensatory damages of $1.1 million and allocating 55% of the fault to PM USA (an amount of $605,000 ). The jury also awarded plaintiff $1.3 million in punitive damages against PM USA. Post-Trial Developments: In May 2017, PM USA filed various post-trial motions, including motions to set aside the verdict and for a new trial. In June 2017, the trial court entered final judgment in favor of plaintiff with a deduction for plaintiff’s comparative fault. In August 2017, the court denied PM USA’s post-trial motions and PM USA filed a notice of appeal to the Florida Third District Court of Appeal and posted a bond in the amount of approximately $2 million . In September 2017, plaintiff cross-appealed. ______________________________________________________________________________________________________ Plaintiff: Sommers Date: April 2017 Verdict: A Miami-Dade County jury returned a verdict in favor of plaintiff and against PM USA awarding compensatory damages of $1 million . The court dismissed the punitive damages claim prior to trial. Post-Trial Developments: In April 2017, PM USA filed motions for a new trial and for a directed verdict, and plaintiff filed a motion for a new trial on punitive damages. In January 2018, the trial court granted plaintiff’s motion for a new trial on punitive damages, denied PM USA’s post-trial motions, and PM USA filed a notice of appeal to the Florida Third District Court of Appeal. In February 2018, plaintiff cross-appealed. In April 2018, the trial court entered an amended final judgment in favor of plaintiff. In May 2018, PM USA filed a notice of appeal to the Florida Third District Court of Appeal to review the amended final judgment and posted a bond in the amount of $1 million . ______________________________________________________________________________________________________ Plaintiff: Santoro Date: March 2017 Verdict: A Broward County jury returned a verdict in favor of plaintiff and against PM USA, R.J. Reynolds and Liggett Group LLC (“Liggett Group”) awarding compensatory damages of $1.6 million . The jury also awarded plaintiff $100,000 in punitive damages against PM USA. Post-Trial Developments: In April 2017, the trial court entered final judgment in favor of plaintiff with a deduction for plaintiff’s comparative fault and defendants filed various post-trial motions, including motions to set aside the verdict and for a new trial. In December 2017, the trial court granted defendants’ motion to set aside the verdict as to all claims except plaintiff’s conspiracy claim. In January 2018, plaintiff filed a motion to amend the final judgment to award the full compensatory damages without reduction for plaintiff’s comparative fault. In May 2018, the trial court denied defendants’ remaining post-trial motions, but set aside the punitive damages award. The trial court also granted plaintiff’s motion to amend the final judgment to award full compensatory damages. In June 2018, defendants filed a notice of appeal to the Florida Fourth District Court of Appeal and plaintiff filed a notice of cross-appeal. PM USA subsequently posted a bond in the amount of approximately $1 mil

Condensed Consolidating Financi

Condensed Consolidating Financial Information	9 Months Ended
	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidating Financial Information	Condensed Consolidating Financial Information: PM USA, which is a 100% owned subsidiary of Altria, has guaranteed Altria’s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its commercial paper program (the “Guarantees”). Pursuant to the Guarantees, PM USA fully and unconditionally guarantees, as primary obligor, the payment and performance of Altria’s obligations under the guaranteed debt instruments (the “Obligations”), subject to release under certain customary circumstances as noted below. The Guarantees provide that PM USA guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations. The liability of PM USA under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, Altria or PM USA. The obligations of PM USA under the Guarantees are limited to the maximum amount as will not result in PM USA’s obligations under the Guarantees constituting a fraudulent transfer or conveyance, after giving effect to such maximum amount and all other contingent and fixed liabilities of PM USA that are relevant under Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to the Guarantees. For this purpose, “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors. PM USA will be unconditionally released and discharged from the Obligations upon the earliest to occur of: ▪ the date, if any, on which PM USA consolidates with or merges into Altria or any successor; ▪ the date, if any, on which Altria or any successor consolidates with or merges into PM USA; ▪ the payment in full of the Obligations pertaining to such Guarantees; and ▪ the rating of Altria’s long-term senior unsecured debt by Standard & Poor’s Ratings Services of A or higher. At September 30, 2018 , the respective principal 100% owned subsidiaries of Altria and PM USA were not limited by long-term debt or other agreements in their ability to pay cash dividends or make other distributions with respect to their equity interests. The following sets forth the condensed consolidating balance sheets as of September 30, 2018 and December 31, 2017 , condensed consolidating statements of earnings and comprehensive earnings for the nine and three months ended September 30, 2018 and 2017 , and condensed consolidating statements of cash flows for the nine months ended September 30, 2018 and 2017 for Altria, PM USA and, collectively, Altria’s other subsidiaries that are not guarantors of Altria’s debt instruments (the “Non-Guarantor Subsidiaries”). The financial information may not necessarily be indicative of results of operations or financial position had PM USA and the Non-Guarantor Subsidiaries operated as independent entities. Altria and PM USA account for investments in their subsidiaries under the equity method of accounting. Condensed Consolidating Balance Sheets September 30, 2018 (in millions of dollars) Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Assets Cash and cash equivalents $ 2,346 $ — $ 47 $ — $ 2,393 Receivables — 14 173 — 187 Inventories: Leaf tobacco — 465 329 — 794 Other raw materials — 114 74 — 188 Work in process — 4 502 — 506 Finished product — 117 472 — 589 — 700 1,377 — 2,077 Due from Altria and subsidiaries 7 4,085 1,233 (5,325 ) — Income taxes — 223 — (139 ) 84 Other current assets 56 334 34 — 424 Total current assets 2,409 5,356 2,864 (5,464 ) 5,165 Property, plant and equipment, at cost — 2,910 1,951 — 4,861 Less accumulated depreciation — 2,100 870 — 2,970 — 810 1,081 — 1,891 Goodwill — — 5,307 — 5,307 Other intangible assets, net — 2 12,383 — 12,385 Investment in AB InBev 17,825 — — — 17,825 Investment in consolidated subsidiaries 14,081 2,861 — (16,942 ) — Finance assets, net — — 848 — 848 Due from Altria and subsidiaries 4,790 — — (4,790 ) — Other assets 159 717 144 (488 ) 532 Total Assets $ 39,264 $ 9,746 $ 22,627 $ (27,684 ) $ 43,953 Condensed Consolidating Balance Sheets (Continued) September 30, 2018 (in millions of dollars) Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Liabilities Current portion of long-term debt $ 2,007 $ — $ — $ — $ 2,007 Accounts payable — 78 211 — 289 Accrued liabilities: Marketing — 578 112 — 690 Employment costs 14 11 122 — 147 Settlement charges — 3,222 8 — 3,230 Other 277 335 302 (139 ) 775 Dividends payable 1,508 — — — 1,508 Due to Altria and subsidiaries 4,814 426 85 (5,325 ) — Total current liabilities 8,620 4,650 840 (5,464 ) 8,646 Long-term debt 11,896 — — — 11,896 Deferred income taxes 2,963 — 2,952 (488 ) 5,427 Accrued pension costs 197 — 63 — 260 Accrued postretirement health care costs — 1,213 770 — 1,983 Due to Altria and subsidiaries — — 4,790 (4,790 ) — Other liabilities 94 30 83 — 207 Total liabilities 23,770 5,893 9,498 (10,742 ) 28,419 Contingencies Redeemable noncontrolling interest — — 38 — 38 Stockholders’ Equity Common stock 935 — 9 (9 ) 935 Additional paid-in capital 5,959 3,310 12,236 (15,546 ) 5,959 Earnings reinvested in the business 43,805 801 2,241 (3,042 ) 43,805 Accumulated other comprehensive losses (2,034 ) (258 ) (1,397 ) 1,655 (2,034 ) Cost of repurchased stock (33,171 ) — — — (33,171 ) Total stockholders’ equity attributable to Altria 15,494 3,853 13,089 (16,942 ) 15,494 Noncontrolling interests — — 2 — 2 Total stockholders’ equity 15,494 3,853 13,091 (16,942 ) 15,496 Total Liabilities and Stockholders’ Equity $ 39,264 $ 9,746 $ 22,627 $ (27,684 ) $ 43,953 Condensed Consolidating Balance Sheets December 31, 2017 (in millions of dollars) Altria PM USA Non- Total Consolidated Assets Cash and cash equivalents $ 1,203 $ 1 $ 49 $ — $ 1,253 Receivables 1 10 131 — 142 Inventories: Leaf tobacco — 579 362 — 941 Other raw materials — 111 59 — 170 Work in process — 5 555 — 560 Finished product — 128 426 — 554 — 823 1,402 — 2,225 Due from Altria and subsidiaries 2 2,413 1,022 (3,437 ) — Income taxes — 542 17 (98 ) 461 Other current assets 11 147 105 — 263 Total current assets 1,217 3,936 2,726 (3,535 ) 4,344 Property, plant and equipment, at cost — 2,930 1,949 — 4,879 Less accumulated depreciation — 2,086 879 — 2,965 — 844 1,070 — 1,914 Goodwill — — 5,307 — 5,307 Other intangible assets, net — 2 12,398 — 12,400 Investment in AB InBev 17,952 — — — 17,952 Investment in consolidated subsidiaries 13,111 2,818 — (15,929 ) — Finance assets, net — — 899 — 899 Due from Altria and subsidiaries 4,790 — — (4,790 ) — Other assets 34 671 157 (476 ) 386 Total Assets $ 37,104 $ 8,271 $ 22,557 $ (24,730 ) $ 43,202 Condensed Consolidating Balance Sheets (Continued) December 31, 2017 (in millions of dollars) Altria PM USA Non- Total Consolidated Liabilities Current portion of long-term debt $ 864 $ — $ — $ — $ 864 Accounts payable 2 91 281 — 374 Accrued liabilities: Marketing — 578 117 — 695 Employment costs 21 14 153 — 188 Settlement charges — 2,437 5 — 2,442 Other 389 433 247 (98 ) 971 Dividends payable 1,258 — — — 1,258 Due to Altria and subsidiaries 3,040 317 80 (3,437 ) — Total current liabilities 5,574 3,870 883 (3,535 ) 6,792 Long-term debt 13,030 — — — 13,030 Deferred income taxes 2,809 — 2,914 (476 ) 5,247 Accrued pension costs 206 — 239 — 445 Accrued postretirement health care costs — 1,214 773 — 1,987 Due to Altria and subsidiaries — — 4,790 (4,790 ) — Other liabilities 108 49 126 — 283 Total liabilities 21,727 5,133 9,725 (8,801 ) 27,784 Contingencies Redeemable noncontrolling interest — — 38 — 38 Stockholders’ Equity Common stock 935 — 9 (9 ) 935 Additional paid-in capital 5,952 3,310 12,045 (15,355 ) 5,952 Earnings reinvested in the business 42,251 96 2,243 (2,339 ) 42,251 Accumulated other comprehensive losses (1,897 ) (268 ) (1,506 ) 1,774 (1,897 ) Cost of repurchased stock (31,864 ) — — — (31,864 ) Total stockholders’ equity attributable to Altria 15,377 3,138 12,791 (15,929 ) 15,377 Noncontrolling interests — — 3 — 3 Total stockholders’ equity 15,377 3,138 12,794 (15,929 ) 15,380 Total Liabilities and Stockholders’ Equity $ 37,104 $ 8,271 $ 22,557 $ (24,730 ) $ 43,202 Condensed Consolidating Statements of Earnings and Comprehensive Earnings For the Nine Months Ended September 30, 2018 (in millions of dollars) Altria PM USA Non- Total Consolidated Net revenues $ — $ 16,339 $ 2,938 $ (27 ) $ 19,250 Cost of sales — 4,666 870 (27 ) 5,509 Excise taxes on products — 4,245 164 — 4,409 Gross profit — 7,428 1,904 — 9,332 Marketing, administration and research costs 122 1,400 437 — 1,959 Asset impairment and exit costs — — 2 — 2 Operating (expense) income (122 ) 6,028 1,465 — 7,371 Interest and other debt expense (income), net 378 (37 ) 162 — 503 Net periodic benefit cost (income), excluding service cost 3 (33 ) (7 ) — (37 ) Earnings from equity investment in AB InBev (759 ) — — — (759 ) Loss on AB InBev/SABMiller business combination 33 — — — 33 Earnings before income taxes and equity earnings of subsidiaries 223 6,098 1,310 — 7,631 Provision for income taxes 67 1,537 311 — 1,915 Equity earnings of subsidiaries 5,557 310 — (5,867 ) — Net earnings 5,713 4,871 999 (5,867 ) 5,716 Net earnings attributable to noncontrolling interests — — (3 ) — (3 ) Net earnings attributable to Altria $ 5,713 $ 4,871 $ 996 $ (5,867 ) $ 5,713 Net earnings $ 5,713 $ 4,871 $ 999 $ (5,867 ) $ 5,716 Other comprehensive (losses) earnings, net of deferred income taxes (137 ) 10 109 (119 ) (137 ) Comprehensive earnings 5,576 4,881 1,108 (5,986 ) 5,579 Comprehensive earnings attributable to noncontrolling interests — — (3 ) — (3 ) Comprehensive earnings attributable to Altria $ 5,576 $ 4,881 $ 1,105 $ (5,986 ) $ 5,576 Condensed Consolidating Statements of Earnings and Comprehensive Earnings For the Nine Months Ended September 30, 2017 (in millions of dollars) Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Net revenues $ — $ 16,748 $ 2,754 $ (27 ) $ 19,475 Cost of sales — 4,888 858 (27 ) 5,719 Excise taxes on products — 4,533 162 — 4,695 Gross profit — 7,327 1,734 — 9,061 Marketing, administration and research costs 125 1,223 333 — 1,681 Asset impairment and exit costs — — 24 — 24 Operating (expense) income (125 ) 6,104 1,377 — 7,356 Interest and other debt expense (income), net 375 (12 ) 162 — 525 Net periodic benefit cost (income), excluding service cost 1 (28 ) (10 ) — (37 ) Earnings from equity investment in AB InBev (332 ) — — — (332 ) Gain on AB InBev/SABMiller business combination (445 ) — — — (445 ) Earnings before income taxes and equity earnings of subsidiaries 276 6,144 1,225 — 7,645 (Benefit) provision for income taxes (207 ) 2,173 420 — 2,386 Equity earnings of subsidiaries 4,773 234 — (5,007 ) — Net earnings 5,256 4,205 805 (5,007 ) 5,259 Net earnings attributable to noncontrolling interests — — (3 ) — (3 ) Net earnings attributable to Altria $ 5,256 $ 4,205 $ 802 $ (5,007 ) $ 5,256 Net earnings $ 5,256 $ 4,205 $ 805 $ (5,007 ) $ 5,259 Other comprehensive earnings, net of deferred income taxes 106 10 83 (93 ) 106 Comprehensive earnings 5,362 4,215 888 (5,100 ) 5,365 Comprehensive earnings attributable to noncontrolling interests — — (3 ) — (3 ) Comprehensive earnings attributable to Altria $ 5,362 $ 4,215 $ 885 $ (5,100 ) $ 5,362 Condensed Consolidating Statements of Earnings and Comprehensive Earnings For the Three Months Ended September 30, 2018 (in millions of dollars) Altria PM USA Non- Total Consolidated Net revenues $ — $ 5,811 $ 1,035 $ (9 ) $ 6,837 Cost of sales — 1,736 310 (9 ) 2,037 Excise taxes on products — 1,491 54 — 1,545 Gross profit — 2,584 671 — 3,255 Marketing, administration and research costs 45 491 164 — 700 Asset impairment and exit costs — — (2 ) — (2 ) Operating (expense) income (45 ) 2,093 509 — 2,557 Interest and other debt expense (income), net 127 (20 ) 52 — 159 Net periodic benefit cost (income), excluding service cost 1 (18 ) (4 ) — (21 ) Earnings from equity investment in AB InBev (189 ) — — — (189 ) Earnings before income taxes and equity earnings of subsidiaries 16 2,131 461 — 2,608 Provision for income taxes 21 539 104 — 664 Equity earnings of subsidiaries 1,948 119 — (2,067 ) — Net earnings 1,943 1,711 357 (2,067 ) 1,944 Net earnings attributable to noncontrolling interests — — (1 ) — (1 ) Net earnings attributable to Altria $ 1,943 $ 1,711 $ 356 $ (2,067 ) $ 1,943 Net earnings $ 1,943 $ 1,711 $ 357 $ (2,067 ) $ 1,944 Other comprehensive (losses) earnings, net of deferred income taxes (382 ) 2 36 (38 ) (382 ) Comprehensive earnings 1,561 1,713 393 (2,105 ) 1,562 Comprehensive earnings attributable to noncontrolling interests — — (1 ) — (1 ) Comprehensive earnings attributable to Altria $ 1,561 $ 1,713 $ 392 $ (2,105 ) $ 1,561 Condensed Consolidating Statements of Earnings and Comprehensive Earnings For the Three Months Ended September 30, 2017 (in millions of dollars) Altria PM USA Non- Total Consolidated Net revenues $ — $ 5,764 $ 974 $ (9 ) $ 6,729 Cost of sales — 1,668 293 (9 ) 1,952 Excise taxes on products — 1,551 55 — 1,606 Gross profit — 2,545 626 — 3,171 Marketing, administration and research costs 46 422 106 — 574 Asset impairment and exit costs — — 8 — 8 Operating (expense) income (46 ) 2,123 512 — 2,589 Interest and other debt expense (income), net 122 (6 ) 53 — 169 Net periodic benefit cost (income), excluding service cost — (14 ) (4 ) — (18 ) Earnings from equity investment in AB InBev (169 ) — — — (169 ) Gain on AB InBev/SABMiller business combination (37 ) — — — (37 ) Earnings before income taxes and equity earnings of subsidiaries 38 2,143 463 — 2,644 (Benefit) provision for income taxes (167 ) 776 168 — 777 Equity earnings of subsidiaries 1,661 82 — (1,743 ) — Net earnings 1,866 1,449 295 (1,743 ) 1,867 Net earnings attributable to noncontrolling interests — — (1 ) — (1 ) Net earnings attributable to Altria $ 1,866 $ 1,449 $ 294 $ (1,743 ) $ 1,866 Net earnings $ 1,866 $ 1,449 $ 295 $ (1,743 ) $ 1,867 Other comprehensive (losses) earnings, net of deferred income taxes (108 ) 3 27 (30 ) (108 ) Comprehensive earnings 1,758 1,452 322 (1,773 ) 1,759 Comprehensive earnings attributable to noncontrolling interests — — (1 ) — (1 ) Comprehensive earnings attributable to Altria $ 1,758 $ 1,452 $ 321 $ (1,773 ) $ 1,758 Condensed Consolidating Statements of Cash Flows For the Nine Months Ended September 30, 2018 (in millions of dollars) Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Cash Provided by Operating Activities Net cash provided by operating activities $ 4,806 $ 5,801 $ 1,123 $ (5,164 ) $ 6,566 Cash Provided by (Used in) Investing Activities Capital expenditures — (33 ) (99 ) — (132 ) Other 8 — (13 ) — (5 ) Net cash provided by (used in) investing activities 8 (33 ) (112 ) — (137 ) Cash Provided by (Used in) Financing Activities Repurchases of common stock (1,317 ) — — — (1,317 ) Dividends paid on common stock (3,909 ) — — — (3,909 ) Changes in amounts due to/from Altria and subsidiaries 1,576 (1,565 ) (11 ) — — Cash dividends paid to parent — (4,166 ) (998 ) 5,164 — Other (21 ) — (4 ) — (25 ) Net cash used in financing activities (3,671 ) (5,731 ) (1,013 ) 5,164 (5,251 ) Cash, cash equivalents and restricted cash (1) : Increase (decrease) 1,143 37 (2 ) — 1,178 Balance at beginning of period 1,203 62 49 — 1,314 Balance at end of period $ 2,346 $ 99 $ 47 $ — $ 2,492 (1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 10 . Contingencies . Condensed Consolidating Statements of Cash Flows For the Nine Months Ended September 30, 2017 (in millions of dollars) Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Cash Provided by Operating Activities Net cash provided by operating activities $ 4,777 $ 3,664 $ 639 $ (4,936 ) $ 4,144 Cash Provided by (Used in) Investing Activities Capital expenditures — (21 ) (130 ) — (151 ) Proceeds from finance assets — — 133 — 133 Other (4 ) 2 (182 ) — (184 ) Net cash used in investing activities (4 ) (19 ) (179 ) — (202 ) Cash Provided by (Used in) Financing Activities Repurchases of common stock (2,359 ) — — — (2,359 ) Dividends paid on common stock (3,544 ) — — — (3,544 ) Changes in amounts due to/from Altria and subsidiaries (813 ) 182 631 — — Cash dividends paid to parent — (3,849 ) (1,087 ) 4,936 — Other (40 ) — (7 ) — (47 ) Net cash used in financing activities (6,756 ) (3,667 ) (463 ) 4,936 (5,950 ) Cash, cash equivalents and restricted cash (1) : Decrease (1,983 ) (22 ) (3 ) — (2,008 ) Balance at beginning of period 4,521 83 47 — 4,651 Balance at end of period $ 2,538 $ 61 $ 44 $ — $ 2,643 (1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 10 . Contingencies .

Recent Accounting Guidance Not

Recent Accounting Guidance Not Yet Adopted	9 Months Ended
	Sep. 30, 2018
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recent Accounting Guidance Not Yet Adopted	Recent Accounting Guidance Not Yet Adopted: The following table provides a description of the recently issued accounting guidance applicable to, but not yet adopted by, Altria: Standards Description Effective Date for Public Entity Effect on Financial Statements ASU Nos. 2016-02; 2018-01; 2018-10; 2018-11 Leases (Topic 842) The guidance requires entities to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. The guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. Early adoption is permitted. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures, including identifying and analyzing all contracts that contain a lease. As a lessor, PMCC maintains a portfolio of finance assets, substantially all of which are leveraged leases, the accounting of which will be unchanged under the new guidance and is not expected to change unless there is a contract modification to an existing lease. As lessees, Altria and its subsidiaries’ various leases under existing guidance are classified as operating leases that are not recorded on Altria’s consolidated balance sheets but are recorded in Altria’s consolidated statements of earnings as expense is incurred. Altria plans to apply the new guidance retrospectively at the beginning of the period of adoption and will record substantially all leases on its consolidated balance sheets as a right-of-use asset and a lease liability. Altria does not expect its adoption of this guidance to have a material impact on Altria’s consolidated financial statements. The guidance will result in expanded footnote disclosures. ASU No. 2016-13 Measurement of Credit Losses on Financial Instruments (Topic 326) The guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. Altria and its subsidiaries’ financial assets that are within the scope of the new guidance were approximately 2% of Altria’s consolidated assets at September 30, 2018. ASU No. 2018-02 Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (Topic 220) The guidance allows an entity to elect to reclassify the income tax effects of the Tax Reform Act on items within accumulated other comprehensive income to retained earnings. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted in any interim period for which financial statements have not yet been issued. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. ASU No. 2018-15 Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (Subtopic 350-40) The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.

Background and Basis of Prese_2

Background and Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
New Accounting Pronouncements	On January 1, 2018, Altria adopted the following Accounting Standards Updates (“ASU”): ▪ ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) and all related ASU amendments (collectively “ASU No. 2014-09”); ▪ ASU No. 2016-01, Financial Instruments-Overall (Subtopic 825-10) : Recognition and Measurement of Financial Assets and Financial Liabilities and the related ASU amendment (collectively “ASU No. 2016-01”); ▪ ASU No. 2016-15, Statement of Cash Flows (Topic 230) : Classification of Certain Cash Receipts and Cash Payments (“ASU No. 2016-15”); ▪ ASU No. 2016-18, Statement of Cash Flows (Topic 230) : Restricted Cash (“ASU No. 2016-18”); and ▪ ASU No. 2017-07, Compensation-Retirement Benefits (Topic 715) : Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (“ASU No. 2017-07”). Altria has reclassified certain prior-period amounts to conform with the current period’s presentation due to Altria’s adoptions of ASU No. 2016-18 and ASU No. 2017-07. ASU No. 2014-09 establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from an entity’s contracts with customers. Altria has elected to apply the guidance using the modified retrospective transition method. For further discussion, see Note 2 . Revenues from Contracts with Customers . ASU No. 2016-01 addresses certain aspects of the recognition, measurement, presentation and disclosure of financial instruments. The adoption of ASU No. 2016-01 did not impact Altria’s condensed consolidated financial statements. ASU No. 2016-15 addresses how eight specific cash flow issues are to be presented and classified in the statement of cash flows. The adoption of ASU 2016-15 did not impact Altria’s condensed consolidated statements of cash flows. In addition, Altria made an accounting policy election to continue to classify distributions received from equity method investees using the nature of distribution approach. ASU No. 2016-18, which Altria adopted retrospectively, requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash and restricted cash equivalents. As a result of the adoption, restricted cash of $99 million , $61 million , $61 million and $82 million at September 30, 2018, September 30, 2017, December 31, 2017 and December 31, 2016, respectively, was included in cash, cash equivalents and restricted cash on the condensed consolidated statements of cash flows. ASU No. 2017-07 requires an employer to report the service cost component of net periodic pension cost and net periodic postretirement benefit cost in the same line item or items as other compensation costs arising from services rendered by employees during the period. The other components of net periodic pension cost and net periodic postretirement benefit cost are required to be presented in the statement of earnings separately from the service cost component and outside the subtotal of operating income. Additionally, only the service cost component is eligible for capitalization. Altria retrospectively adopted the guidance for the presentation of the service cost component and the other components of net periodic pension cost and net periodic postretirement benefit cost in the statement of earnings, and prospectively adopted the capitalization of service cost. Altria used the practical expedient provided in ASU No. 2017-07 that permits Altria to use the amounts disclosed in its benefit plans note for the prior comparative periods as the estimation basis for applying the retrospective presentation requirements. For the nine months ended September 30, 2017, the adoption of ASU No. 2017-07 resulted in a reclassification of net periodic benefit income of $20 million and $17 million from cost of sales and marketing, administration and research costs, respectively, to net periodic benefit income, excluding service cost in Altria’s condensed consolidated statement of earnings. For the three months ended September 30, 2017, the adoption of ASU No. 2017-07 resulted in a reclassification of net periodic benefit income of $12 million and $6 million from cost of sales and marketing, administration and research costs, respectively, to net periodic benefit income, excluding service cost in Altria’s condensed consolidated statement of earnings. In addition, certain prior-period segment data has been reclassified to conform with the current period’s presentation. The following table provides a description of the recently issued accounting guidance applicable to, but not yet adopted by, Altria: Standards Description Effective Date for Public Entity Effect on Financial Statements ASU Nos. 2016-02; 2018-01; 2018-10; 2018-11 Leases (Topic 842) The guidance requires entities to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. The guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. Early adoption is permitted. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures, including identifying and analyzing all contracts that contain a lease. As a lessor, PMCC maintains a portfolio of finance assets, substantially all of which are leveraged leases, the accounting of which will be unchanged under the new guidance and is not expected to change unless there is a contract modification to an existing lease. As lessees, Altria and its subsidiaries’ various leases under existing guidance are classified as operating leases that are not recorded on Altria’s consolidated balance sheets but are recorded in Altria’s consolidated statements of earnings as expense is incurred. Altria plans to apply the new guidance retrospectively at the beginning of the period of adoption and will record substantially all leases on its consolidated balance sheets as a right-of-use asset and a lease liability. Altria does not expect its adoption of this guidance to have a material impact on Altria’s consolidated financial statements. The guidance will result in expanded footnote disclosures. ASU No. 2016-13 Measurement of Credit Losses on Financial Instruments (Topic 326) The guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. Altria and its subsidiaries’ financial assets that are within the scope of the new guidance were approximately 2% of Altria’s consolidated assets at September 30, 2018. ASU No. 2018-02 Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (Topic 220) The guidance allows an entity to elect to reclassify the income tax effects of the Tax Reform Act on items within accumulated other comprehensive income to retained earnings. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted in any interim period for which financial statements have not yet been issued. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. ASU No. 2018-15 Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (Subtopic 350-40) The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.
Investment in AB InBev	Altria reviews its investment in AB InBev for impairment by comparing the fair value of its investment to its carrying value. If the carrying value of its investment exceeds its fair value and the loss in value is other than temporary, the investment is considered impaired and impairment is recognized in the period identified. The factors used to make this determination include the duration and magnitude of the fair value decline, AB InBev’s financial condition and near-term prospects, and Altria’s intent and ability to hold its investment in AB InBev until recovery. The fair value of Altria’s equity investment in AB InBev is based on: (i) unadjusted quoted prices in active markets for AB InBev’s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy. Altria may, in certain instances, pledge or otherwise grant a security interest in all or part of its Restricted Shares. In the event the pledgee or security interest holder forecloses on the Restricted Shares, the relevant Restricted Shares will be automatically converted, one-for-one, into ordinary shares. Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.

Background and Basis of Prese_3

Background and Basis of Presentation (Tables)	9 Months Ended
	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Share Repurchase Activity	Altria’s share repurchase activity was as follows: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions, except per share data) Total number of shares repurchased 21.8 33.2 6.2 11.1 Aggregate cost of shares repurchased $ 1,317 $ 2,359 $ 367 $ 759 Average price per share of shares repurchased $ 60.53 $ 70.97 $ 59.18 $ 67.99

Benefit Plans (Tables)

Benefit Plans (Tables)	9 Months Ended
	Sep. 30, 2018
Retirement Benefits [Abstract]
Schedule of Net Periodic Benefit (Income) Cost	Net periodic benefit cost (income) consisted of the following: For the Nine Months Ended September 30, For the Three Months Ended September 30, Pension Postretirement Pension Postretirement 2018 2017 2018 2017 2018 2017 2018 2017 (in millions) Service cost $ 61 $ 57 $ 13 $ 12 $ 20 $ 19 $ 4 $ 3 Interest cost 207 216 52 57 69 72 15 17 Expected return on plan assets (438 ) (451 ) (14 ) — (146 ) (151 ) (5 ) — Amortization: Net loss 168 147 16 19 56 49 (1 ) 3 Prior service cost (credit) 3 3 (31 ) (28 ) 1 1 (10 ) (9 ) Net periodic benefit cost (income) $ 1 $ (28 ) $ 36 $ 60 $ — $ (10 ) $ 3 $ 14

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2018
Earnings Per Share [Abstract]
Earnings Per Share	Basic and diluted earnings per share (“EPS”) were calculated using the following: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Net earnings attributable to Altria $ 5,713 $ 5,256 $ 1,943 $ 1,866 Less: Distributed and undistributed earnings attributable to share-based awards (7 ) (7 ) (2 ) (2 ) Earnings for basic and diluted EPS $ 5,706 $ 5,249 $ 1,941 $ 1,864 Weighted-average shares for basic and diluted EPS 1,891 1,927 1,883 1,915

Other Comprehensive Earnings__2

Other Comprehensive Earnings/Losses (Tables)	9 Months Ended
	Sep. 30, 2018
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The following tables set forth the changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria: For the Nine Months Ended September 30, 2018 Benefit Plans AB InBev Currency Translation Adjustments and Other Accumulated Other Comprehensive Losses (in millions) Balances, December 31, 2017 $ (1,839 ) $ (54 ) $ (4 ) $ (1,897 ) Other comprehensive losses before reclassifications — (288 ) (1 ) (289 ) Deferred income taxes — 57 — 57 Other comprehensive losses before reclassifications, net of deferred income taxes — (231 ) (1 ) (232 ) Amounts reclassified to net earnings 168 (41 ) — 127 Deferred income taxes (42 ) 10 — (32 ) Amounts reclassified to net earnings, net of deferred income taxes 126 (31 ) — 95 Other comprehensive earnings (losses), net of deferred income taxes 126 (262 ) (1 ) (1 ) (137 ) Balances, September 30, 2018 $ (1,713 ) $ (316 ) $ (5 ) $ (2,034 ) For the Three Months Ended September 30, 2018 Benefit Plans AB InBev Currency Translation Adjustments and Other Accumulated Other Comprehensive Losses (in millions) Balances, June 30, 2018 $ (1,752 ) $ 106 $ (6 ) $ (1,652 ) Other comprehensive (losses) earnings before reclassifications — (513 ) 1 (512 ) Deferred income taxes — 107 — 107 Other comprehensive (losses) earnings before reclassifications, net of deferred income taxes — (406 ) 1 (405 ) Amounts reclassified to net earnings 50 (21 ) — 29 Deferred income taxes (11 ) 5 — (6 ) Amounts reclassified to net earnings, net of deferred income taxes 39 (16 ) — 23 Other comprehensive earnings (losses), net of deferred income taxes 39 (422 ) (1 ) 1 (382 ) Balances, September 30, 2018 $ (1,713 ) $ (316 ) $ (5 ) $ (2,034 ) For the Nine Months Ended September 30, 2017 Benefit Plans AB InBev Currency Translation Adjustments and Other Accumulated Other Comprehensive Losses (in millions) Balances, December 31, 2016 $ (2,048 ) $ — $ (4 ) $ (2,052 ) Other comprehensive earnings before reclassifications — 9 1 10 Deferred income taxes — (3 ) — (3 ) Other comprehensive earnings before reclassifications, net of deferred income taxes — 6 1 7 Amounts reclassified to net earnings 154 5 — 159 Deferred income taxes (58 ) (2 ) — (60 ) Amounts reclassified to net earnings, net of deferred income taxes 96 3 — 99 Other comprehensive earnings, net of deferred income taxes 96 9 (1 ) 1 106 Balances, September 30, 2017 $ (1,952 ) $ 9 $ (3 ) $ (1,946 ) For the Three Months Ended September 30, 2017 Benefit Plans AB InBev Currency Translation Adjustments and Other Accumulated Other Comprehensive Losses (in millions) Balances, June 30, 2017 $ (1,983 ) $ 148 $ (3 ) $ (1,838 ) Other comprehensive losses before reclassifications — (216 ) — (216 ) Deferred income taxes — 75 — 75 Other comprehensive losses before reclassifications, net of deferred income taxes — (141 ) — (141 ) Amounts reclassified to net earnings 48 3 — 51 Deferred income taxes (17 ) (1 ) — (18 ) Amounts reclassified to net earnings, net of deferred income taxes 31 2 — 33 Other comprehensive earnings (losses), net of deferred income taxes 31 (139 ) (1 ) — (108 ) Balances, September 30, 2017 $ (1,952 ) $ 9 $ (3 ) $ (1,946 ) (1) Primarily reflects currency translation adjustments.
Reclassification out of Accumulated Other Comprehensive Income	The following table sets forth pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Benefit Plans: (1) Net loss $ 196 $ 179 $ 59 $ 56 Prior service cost/credit (28 ) (25 ) (9 ) (8 ) 168 154 50 48 AB InBev (2) (41 ) 5 (21 ) 3 Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings $ 127 $ 159 $ 29 $ 51 (1) Amounts are included in net defined benefit plan costs. For further details, see Note 4 . Benefit Plans. (2) Amounts are primarily included in earnings from equity investment in AB InBev.

Segment Reporting (Tables)

Segment Reporting (Tables)	9 Months Ended
	Sep. 30, 2018
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	Pre-tax asset impairment, exit and implementation costs recorded in connection with the facilities consolidation consisted of the following: For the Nine Months Ended September 30, 2018 For the Nine Months Ended September 30, 2017 Asset Impairment and Exit Costs Implementation Costs (1) Total Asset Impairment and Exit Costs Implementation Costs (1) Total (in millions) Smokeable products $ (4 ) $ 1 $ (3 ) $ 2 $ 17 $ 19 Smokeless products 6 3 9 22 30 52 Total $ 2 $ 4 $ 6 $ 24 $ 47 $ 71 For the Three Months Ended September 30, 2018 For the Three Months Ended September 30, 2017 Asset Impairment and Exit Costs Implementation Costs (1) Total Asset Impairment and Exit Costs Implementation Costs (1) Total (in millions) Smokeable products $ (5 ) $ (1 ) $ (6 ) $ — $ 5 $ 5 Smokeless products 3 — 3 8 2 10 Total $ (2 ) $ (1 ) $ (3 ) $ 8 $ 7 $ 15 (1) The pre-tax implementation costs were included in cost of sales in Altria’s condensed consolidated statements of earnings. Segment data were as follows: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Net revenues: Smokeable products $ 16,995 $ 17,355 $ 6,035 $ 5,975 Smokeless products 1,690 1,580 586 550 Wine 489 471 181 181 All other 76 69 35 23 Net revenues $ 19,250 $ 19,475 $ 6,837 $ 6,729 Earnings before income taxes: Operating companies income (loss): Smokeable products $ 6,516 $ 6,536 $ 2,277 $ 2,276 Smokeless products 1,085 941 370 348 Wine 73 82 29 36 All other (121 ) (31 ) (38 ) (10 ) Amortization of intangibles (30 ) (15 ) (20 ) (5 ) General corporate expenses (152 ) (157 ) (61 ) (56 ) Operating income 7,371 7,356 2,557 2,589 Interest and other debt expense, net (503 ) (525 ) (159 ) (169 ) Net periodic benefit income, excluding service cost 37 37 21 18 Earnings from equity investment in AB InBev 759 332 189 169 (Loss) gain on AB InBev/SABMiller business combination (33 ) 445 — 37 Earnings before income taxes $ 7,631 $ 7,645 $ 2,608 $ 2,644
Schedule of NPM Adjustment	Non-Participating Manufacturer (“NPM”) Adjustment Items - Pre-tax (income) expense for NPM adjustment items was recorded in Altria’s condensed consolidated statements of earnings as follows: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Smokeable products segment $ (145 ) $ (5 ) $ — $ 3 Interest and other debt expense, net — 9 — 2 Total $ (145 ) $ 4 $ — $ 5
Schedule of Pre-tax Tobacco and Health Litigation Items	Tobacco and Health Litigation Items - Pre-tax charges related to certain tobacco and health litigation items were recorded in Altria’s condensed consolidated statements of earnings as follows: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Smokeable products segment $ 94 $ 16 $ 10 $ — Smokeless products segment 10 — 10 — Interest and other debt expense, net 15 2 1 — Total $ 119 $ 18 $ 21 $ —

Contingencies (Tables)

Contingencies (Tables)	9 Months Ended
	Sep. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Schedule of Contingencies	The table below lists the number of certain tobacco-related cases pending in the United States against PM USA and, in some instances, Altria as of October 22, 2018, October 23, 2017 and October 24, 2016: October 22, 2018 October 23, 2017 October 24, 2016 Individual Smoking and Health Cases (1) 101 87 66 Smoking and Health Class Actions and Aggregated Claims Litigation (2) 2 4 5 Health Care Cost Recovery Actions (3) 1 1 1 “Lights/Ultra Lights” Class Actions 2 4 9 (1) Includes 29 cases filed in Massachusetts and 38 non- Engle cases filed in Florida. Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the Engle case (these Engle progeny cases are discussed below in Smoking and Health Litigation - Engle Class Action ). Also does not include 1,491 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (“ETS”). The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 ( Broin ). The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages. In March 2018, 923 of these cases were voluntarily dismissed without prejudice. (2) The 2016 and 2017 pending cases include as one case the 30 civil actions that were to be tried in six consolidated trials in West Virginia ( In re: Tobacco Litigation ). PM USA was a defendant in nine of the 30 cases. The parties resolved these cases for an immaterial amount and in the second quarter of 2018, the court dismissed all 30 cases. (3) See Health Care Cost Recovery Litigation - Federal Government’s Lawsuit below. The changes in Altria’s accrued liability for tobacco and health litigation items, including related interest costs, for the periods specified below are as follows: For the Nine Months Ended September 30, For the Three Months Ended September 30, 2018 2017 2018 2017 (in millions) Accrued liability for tobacco and health litigation items at beginning of period (1) $ 106 $ 47 $ 107 $ 47 Pre-tax charges for: Tobacco and health litigation 104 16 20 — Related interest costs 15 2 1 — Payments (1) (118 ) (18 ) (21 ) — Accrued liability for tobacco and health litigation items at end of period (1) $ 107 $ 47 $ 107 $ 47 (1) Includes amounts related to the costs of implementing the corrective communications remedy related to the Federal Government’s Lawsuit discussed below.

Condensed Consolidating Finan_2

Condensed Consolidating Financial Information (Tables)	9 Months Ended
	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidating Balance Sheet	Condensed Consolidating Balance Sheets September 30, 2018 (in millions of dollars) Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Assets Cash and cash equivalents $ 2,346 $ — $ 47 $ — $ 2,393 Receivables — 14 173 — 187 Inventories: Leaf tobacco — 465 329 — 794 Other raw materials — 114 74 — 188 Work in process — 4 502 — 506 Finished product — 117 472 — 589 — 700 1,377 — 2,077 Due from Altria and subsidiaries 7 4,085 1,233 (5,325 ) — Income taxes — 223 — (139 ) 84 Other current assets 56 334 34 — 424 Total current assets 2,409 5,356 2,864 (5,464 ) 5,165 Property, plant and equipment, at cost — 2,910 1,951 — 4,861 Less accumulated depreciation — 2,100 870 — 2,970 — 810 1,081 — 1,891 Goodwill — — 5,307 — 5,307 Other intangible assets, net — 2 12,383 — 12,385 Investment in AB InBev 17,825 — — — 17,825 Investment in consolidated subsidiaries 14,081 2,861 — (16,942 ) — Finance assets, net — — 848 — 848 Due from Altria and subsidiaries 4,790 — — (4,790 ) — Other assets 159 717 144 (488 ) 532 Total Assets $ 39,264 $ 9,746 $ 22,627 $ (27,684 ) $ 43,953 Condensed Consolidating Balance Sheets (Continued) September 30, 2018 (in millions of dollars) Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Liabilities Current portion of long-term debt $ 2,007 $ — $ — $ — $ 2,007 Accounts payable — 78 211 — 289 Accrued liabilities: Marketing — 578 112 — 690 Employment costs 14 11 122 — 147 Settlement charges — 3,222 8 — 3,230 Other 277 335 302 (139 ) 775 Dividends payable 1,508 — — — 1,508 Due to Altria and subsidiaries 4,814 426 85 (5,325 ) — Total current liabilities 8,620 4,650 840 (5,464 ) 8,646 Long-term debt 11,896 — — — 11,896 Deferred income taxes 2,963 — 2,952 (488 ) 5,427 Accrued pension costs 197 — 63 — 260 Accrued postretirement health care costs — 1,213 770 — 1,983 Due to Altria and subsidiaries — — 4,790 (4,790 ) — Other liabilities 94 30 83 — 207 Total liabilities 23,770 5,893 9,498 (10,742 ) 28,419 Contingencies Redeemable noncontrolling interest — — 38 — 38 Stockholders’ Equity Common stock 935 — 9 (9 ) 935 Additional paid-in capital 5,959 3,310 12,236 (15,546 ) 5,959 Earnings reinvested in the business 43,805 801 2,241 (3,042 ) 43,805 Accumulated other comprehensive losses (2,034 ) (258 ) (1,397 ) 1,655 (2,034 ) Cost of repurchased stock (33,171 ) — — — (33,171 ) Total stockholders’ equity attributable to Altria 15,494 3,853 13,089 (16,942 ) 15,494 Noncontrolling interests — — 2 — 2 Total stockholders’ equity 15,494 3,853 13,091 (16,942 ) 15,496 Total Liabilities and Stockholders’ Equity $ 39,264 $ 9,746 $ 22,627 $ (27,684 ) $ 43,953 Condensed Consolidating Balance Sheets December 31, 2017 (in millions of dollars) Altria PM USA Non- Total Consolidated Assets Cash and cash equivalents $ 1,203 $ 1 $ 49 $ — $ 1,253 Receivables 1 10 131 — 142 Inventories: Leaf tobacco — 579 362 — 941 Other raw materials — 111 59 — 170 Work in process — 5 555 — 560 Finished product — 128 426 — 554 — 823 1,402 — 2,225 Due from Altria and subsidiaries 2 2,413 1,022 (3,437 ) — Income taxes — 542 17 (98 ) 461 Other current assets 11 147 105 — 263 Total current assets 1,217 3,936 2,726 (3,535 ) 4,344 Property, plant and equipment, at cost — 2,930 1,949 — 4,879 Less accumulated depreciation — 2,086 879 — 2,965 — 844 1,070 — 1,914 Goodwill — — 5,307 — 5,307 Other intangible assets, net — 2 12,398 — 12,400 Investment in AB InBev 17,952 — — — 17,952 Investment in consolidated subsidiaries 13,111 2,818 — (15,929 ) — Finance assets, net — — 899 — 899 Due from Altria and subsidiaries 4,790 — — (4,790 ) — Other assets 34 671 157 (476 ) 386 Total Assets $ 37,104 $ 8,271 $ 22,557 $ (24,730 ) $ 43,202 Condensed Consolidating Balance Sheets (Continued) December 31, 2017 (in millions of dollars) Altria PM USA Non- Total Consolidated Liabilities Current portion of long-term debt $ 864 $ — $ — $ — $ 864 Accounts payable 2 91 281 — 374 Accrued liabilities: Marketing — 578 117 — 695 Employment costs 21 14 153 — 188 Settlement charges — 2,437 5 — 2,442 Other 389 433 247 (98 ) 971 Dividends payable 1,258 — — — 1,258 Due to Altria and subsidiaries 3,040 317 80 (3,437 ) — Total current liabilities 5,574 3,870 883 (3,535 ) 6,792 Long-term debt 13,030 — — — 13,030 Deferred income taxes 2,809 — 2,914 (476 ) 5,247 Accrued pension costs 206 — 239 — 445 Accrued postretirement health care costs — 1,214 773 — 1,987 Due to Altria and subsidiaries — — 4,790 (4,790 ) — Other liabilities 108 49 126 — 283 Total liabilities 21,727 5,133 9,725 (8,801 ) 27,784 Contingencies Redeemable noncontrolling interest — — 38 — 38 Stockholders’ Equity Common stock 935 — 9 (9 ) 935 Additional paid-in capital 5,952 3,310 12,045 (15,355 ) 5,952 Earnings reinvested in the business 42,251 96 2,243 (2,339 ) 42,251 Accumulated other comprehensive losses (1,897 ) (268 ) (1,506 ) 1,774 (1,897 ) Cost of repurchased stock (31,864 ) — — — (31,864 ) Total stockholders’ equity attributable to Altria 15,377 3,138 12,791 (15,929 ) 15,377 Noncontrolling interests — — 3 — 3 Total stockholders’ equity 15,377 3,138 12,794 (15,929 ) 15,380 Total Liabilities and Stockholders’ Equity $ 37,104 $ 8,271 $ 22,557 $ (24,730 ) $ 43,202
Condensed Consolidating Statements of Earnings and Comprehensive Earnings	Condensed Consolidating Statements of Earnings and Comprehensive Earnings For the Nine Months Ended September 30, 2018 (in millions of dollars) Altria PM USA Non- Total Consolidated Net revenues $ — $ 16,339 $ 2,938 $ (27 ) $ 19,250 Cost of sales — 4,666 870 (27 ) 5,509 Excise taxes on products — 4,245 164 — 4,409 Gross profit — 7,428 1,904 — 9,332 Marketing, administration and research costs 122 1,400 437 — 1,959 Asset impairment and exit costs — — 2 — 2 Operating (expense) income (122 ) 6,028 1,465 — 7,371 Interest and other debt expense (income), net 378 (37 ) 162 — 503 Net periodic benefit cost (income), excluding service cost 3 (33 ) (7 ) — (37 ) Earnings from equity investment in AB InBev (759 ) — — — (759 ) Loss on AB InBev/SABMiller business combination 33 — — — 33 Earnings before income taxes and equity earnings of subsidiaries 223 6,098 1,310 — 7,631 Provision for income taxes 67 1,537 311 — 1,915 Equity earnings of subsidiaries 5,557 310 — (5,867 ) — Net earnings 5,713 4,871 999 (5,867 ) 5,716 Net earnings attributable to noncontrolling interests — — (3 ) — (3 ) Net earnings attributable to Altria $ 5,713 $ 4,871 $ 996 $ (5,867 ) $ 5,713 Net earnings $ 5,713 $ 4,871 $ 999 $ (5,867 ) $ 5,716 Other comprehensive (losses) earnings, net of deferred income taxes (137 ) 10 109 (119 ) (137 ) Comprehensive earnings 5,576 4,881 1,108 (5,986 ) 5,579 Comprehensive earnings attributable to noncontrolling interests — — (3 ) — (3 ) Comprehensive earnings attributable to Altria $ 5,576 $ 4,881 $ 1,105 $ (5,986 ) $ 5,576 Condensed Consolidating Statements of Earnings and Comprehensive Earnings For the Nine Months Ended September 30, 2017 (in millions of dollars) Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Net revenues $ — $ 16,748 $ 2,754 $ (27 ) $ 19,475 Cost of sales — 4,888 858 (27 ) 5,719 Excise taxes on products — 4,533 162 — 4,695 Gross profit — 7,327 1,734 — 9,061 Marketing, administration and research costs 125 1,223 333 — 1,681 Asset impairment and exit costs — — 24 — 24 Operating (expense) income (125 ) 6,104 1,377 — 7,356 Interest and other debt expense (income), net 375 (12 ) 162 — 525 Net periodic benefit cost (income), excluding service cost 1 (28 ) (10 ) — (37 ) Earnings from equity investment in AB InBev (332 ) — — — (332 ) Gain on AB InBev/SABMiller business combination (445 ) — — — (445 ) Earnings before income taxes and equity earnings of subsidiaries 276 6,144 1,225 — 7,645 (Benefit) provision for income taxes (207 ) 2,173 420 — 2,386 Equity earnings of subsidiaries 4,773 234 — (5,007 ) — Net earnings 5,256 4,205 805 (5,007 ) 5,259 Net earnings attributable to noncontrolling interests — — (3 ) — (3 ) Net earnings attributable to Altria $ 5,256 $ 4,205 $ 802 $ (5,007 ) $ 5,256 Net earnings $ 5,256 $ 4,205 $ 805 $ (5,007 ) $ 5,259 Other comprehensive earnings, net of deferred income taxes 106 10 83 (93 ) 106 Comprehensive earnings 5,362 4,215 888 (5,100 ) 5,365 Comprehensive earnings attributable to noncontrolling interests — — (3 ) — (3 ) Comprehensive earnings attributable to Altria $ 5,362 $ 4,215 $ 885 $ (5,100 ) $ 5,362 Condensed Consolidating Statements of Earnings and Comprehensive Earnings For the Three Months Ended September 30, 2018 (in millions of dollars) Altria PM USA Non- Total Consolidated Net revenues $ — $ 5,811 $ 1,035 $ (9 ) $ 6,837 Cost of sales — 1,736 310 (9 ) 2,037 Excise taxes on products — 1,491 54 — 1,545 Gross profit — 2,584 671 — 3,255 Marketing, administration and research costs 45 491 164 — 700 Asset impairment and exit costs — — (2 ) — (2 ) Operating (expense) income (45 ) 2,093 509 — 2,557 Interest and other debt expense (income), net 127 (20 ) 52 — 159 Net periodic benefit cost (income), excluding service cost 1 (18 ) (4 ) — (21 ) Earnings from equity investment in AB InBev (189 ) — — — (189 ) Earnings before income taxes and equity earnings of subsidiaries 16 2,131 461 — 2,608 Provision for income taxes 21 539 104 — 664 Equity earnings of subsidiaries 1,948 119 — (2,067 ) — Net earnings 1,943 1,711 357 (2,067 ) 1,944 Net earnings attributable to noncontrolling interests — — (1 ) — (1 ) Net earnings attributable to Altria $ 1,943 $ 1,711 $ 356 $ (2,067 ) $ 1,943 Net earnings $ 1,943 $ 1,711 $ 357 $ (2,067 ) $ 1,944 Other comprehensive (losses) earnings, net of deferred income taxes (382 ) 2 36 (38 ) (382 ) Comprehensive earnings 1,561 1,713 393 (2,105 ) 1,562 Comprehensive earnings attributable to noncontrolling interests — — (1 ) — (1 ) Comprehensive earnings attributable to Altria $ 1,561 $ 1,713 $ 392 $ (2,105 ) $ 1,561 Condensed Consolidating Statements of Earnings and Comprehensive Earnings For the Three Months Ended September 30, 2017 (in millions of dollars) Altria PM USA Non- Total Consolidated Net revenues $ — $ 5,764 $ 974 $ (9 ) $ 6,729 Cost of sales — 1,668 293 (9 ) 1,952 Excise taxes on products — 1,551 55 — 1,606 Gross profit — 2,545 626 — 3,171 Marketing, administration and research costs 46 422 106 — 574 Asset impairment and exit costs — — 8 — 8 Operating (expense) income (46 ) 2,123 512 — 2,589 Interest and other debt expense (income), net 122 (6 ) 53 — 169 Net periodic benefit cost (income), excluding service cost — (14 ) (4 ) — (18 ) Earnings from equity investment in AB InBev (169 ) — — — (169 ) Gain on AB InBev/SABMiller business combination (37 ) — — — (37 ) Earnings before income taxes and equity earnings of subsidiaries 38 2,143 463 — 2,644 (Benefit) provision for income taxes (167 ) 776 168 — 777 Equity earnings of subsidiaries 1,661 82 — (1,743 ) — Net earnings 1,866 1,449 295 (1,743 ) 1,867 Net earnings attributable to noncontrolling interests — — (1 ) — (1 ) Net earnings attributable to Altria $ 1,866 $ 1,449 $ 294 $ (1,743 ) $ 1,866 Net earnings $ 1,866 $ 1,449 $ 295 $ (1,743 ) $ 1,867 Other comprehensive (losses) earnings, net of deferred income taxes (108 ) 3 27 (30 ) (108 ) Comprehensive earnings 1,758 1,452 322 (1,773 ) 1,759 Comprehensive earnings attributable to noncontrolling interests — — (1 ) — (1 ) Comprehensive earnings attributable to Altria $ 1,758 $ 1,452 $ 321 $ (1,773 ) $ 1,758
Condensed Consolidating Statements of Cash Flows	Condensed Consolidating Statements of Cash Flows For the Nine Months Ended September 30, 2018 (in millions of dollars) Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Cash Provided by Operating Activities Net cash provided by operating activities $ 4,806 $ 5,801 $ 1,123 $ (5,164 ) $ 6,566 Cash Provided by (Used in) Investing Activities Capital expenditures — (33 ) (99 ) — (132 ) Other 8 — (13 ) — (5 ) Net cash provided by (used in) investing activities 8 (33 ) (112 ) — (137 ) Cash Provided by (Used in) Financing Activities Repurchases of common stock (1,317 ) — — — (1,317 ) Dividends paid on common stock (3,909 ) — — — (3,909 ) Changes in amounts due to/from Altria and subsidiaries 1,576 (1,565 ) (11 ) — — Cash dividends paid to parent — (4,166 ) (998 ) 5,164 — Other (21 ) — (4 ) — (25 ) Net cash used in financing activities (3,671 ) (5,731 ) (1,013 ) 5,164 (5,251 ) Cash, cash equivalents and restricted cash (1) : Increase (decrease) 1,143 37 (2 ) — 1,178 Balance at beginning of period 1,203 62 49 — 1,314 Balance at end of period $ 2,346 $ 99 $ 47 $ — $ 2,492 (1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 10 . Contingencies . Condensed Consolidating Statements of Cash Flows For the Nine Months Ended September 30, 2017 (in millions of dollars) Altria PM USA Non- Guarantor Subsidiaries Total Consolidating Adjustments Consolidated Cash Provided by Operating Activities Net cash provided by operating activities $ 4,777 $ 3,664 $ 639 $ (4,936 ) $ 4,144 Cash Provided by (Used in) Investing Activities Capital expenditures — (21 ) (130 ) — (151 ) Proceeds from finance assets — — 133 — 133 Other (4 ) 2 (182 ) — (184 ) Net cash used in investing activities (4 ) (19 ) (179 ) — (202 ) Cash Provided by (Used in) Financing Activities Repurchases of common stock (2,359 ) — — — (2,359 ) Dividends paid on common stock (3,544 ) — — — (3,544 ) Changes in amounts due to/from Altria and subsidiaries (813 ) 182 631 — — Cash dividends paid to parent — (3,849 ) (1,087 ) 4,936 — Other (40 ) — (7 ) — (47 ) Net cash used in financing activities (6,756 ) (3,667 ) (463 ) 4,936 (5,950 ) Cash, cash equivalents and restricted cash (1) : Decrease (1,983 ) (22 ) (3 ) — (2,008 ) Balance at beginning of period 4,521 83 47 — 4,651 Balance at end of period $ 2,538 $ 61 $ 44 $ — $ 2,643 (1) Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 10 . Contingencies .

Recent Accounting Guidance No_2

Recent Accounting Guidance Not Yet Adopted (Tables)	9 Months Ended
	Sep. 30, 2018
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recent Accounting Guidance Not Yet Adopted	The following table provides a description of the recently issued accounting guidance applicable to, but not yet adopted by, Altria: Standards Description Effective Date for Public Entity Effect on Financial Statements ASU Nos. 2016-02; 2018-01; 2018-10; 2018-11 Leases (Topic 842) The guidance requires entities to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. The guidance is effective for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. Early adoption is permitted. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures, including identifying and analyzing all contracts that contain a lease. As a lessor, PMCC maintains a portfolio of finance assets, substantially all of which are leveraged leases, the accounting of which will be unchanged under the new guidance and is not expected to change unless there is a contract modification to an existing lease. As lessees, Altria and its subsidiaries’ various leases under existing guidance are classified as operating leases that are not recorded on Altria’s consolidated balance sheets but are recorded in Altria’s consolidated statements of earnings as expense is incurred. Altria plans to apply the new guidance retrospectively at the beginning of the period of adoption and will record substantially all leases on its consolidated balance sheets as a right-of-use asset and a lease liability. Altria does not expect its adoption of this guidance to have a material impact on Altria’s consolidated financial statements. The guidance will result in expanded footnote disclosures. ASU No. 2016-13 Measurement of Credit Losses on Financial Instruments (Topic 326) The guidance replaces the current incurred loss impairment methodology for recognizing credit losses for financial assets with a methodology that reflects the entity’s current estimate of all expected credit losses and requires consideration of a broader range of reasonable and supportable information for estimating credit losses. The guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within that reporting period. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. Altria and its subsidiaries’ financial assets that are within the scope of the new guidance were approximately 2% of Altria’s consolidated assets at September 30, 2018. ASU No. 2018-02 Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (Topic 220) The guidance allows an entity to elect to reclassify the income tax effects of the Tax Reform Act on items within accumulated other comprehensive income to retained earnings. The guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted in any interim period for which financial statements have not yet been issued. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures. ASU No. 2018-15 Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (Subtopic 350-40) The guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period. Altria is in the process of evaluating the impact of this guidance on its consolidated financial statements and related disclosures.

Background and Basis of Prese_4

Background and Basis of Presentation (Narrative) (Details) - USD ($) $ / shares in Units, shares in Millions	Dec. 31, 2017	Jan. 31, 2018	Sep. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017	Jan. 31, 2018	Oct. 25, 2018	May 31, 2018	Jul. 31, 2017	Dec. 31, 2016	Oct. 31, 2016	Jul. 31, 2015
Equity, Class of Treasury Stock [Line Items]
Common stock, increase (decrease) in dividend rate, percentage			14.30%	6.10%		21.20%
Dividends declared (usd per share)	$ 0.66		$ 0.8	$ 0.7		$ 2.20	$ 1.88	$ 2.54
Annualized dividend rate (usd per share)						$ 3.20
Repurchase of common stock (shares)			6.2		11.1	21.8	33.2
Aggregate cost of shares repurchased			$ 367,000,000		$ 759,000,000	$ 1,317,000,000	$ 2,359,000,000	$ 2,917,000,000
Average price of repurchased shares, per share (usd per share)			$ 59.18		$ 67.99	$ 60.53	$ 70.97
Net periodic benefit income, excluding service cost			$ 21,000,000		$ 18,000,000	$ 37,000,000	$ 37,000,000
AB InBev [Member]
Equity, Class of Treasury Stock [Line Items]
Fair value of equity investment	$ 22,100,000,000		$ 17,200,000,000			$ 17,200,000,000		22,100,000,000
Equity method investment, ownership percentage (approximately)			10.10%			10.10%
July 2015 Share Repurchase Program [Member]
Equity, Class of Treasury Stock [Line Items]
Planned share repurchase program												$ 4,000,000,000		$ 3,000,000,000	$ 1,000,000,000
Repurchase of common stock (shares)		0.3							58.7
Average price of repurchased shares, per share (usd per share)		$ 71.68							$ 68.15
January 2018 Share Repurchase Program [Member]
Equity, Class of Treasury Stock [Line Items]
Planned share repurchase program		$ 1,000,000,000							$ 1,000,000,000		$ 2,000,000,000
Repurchase of common stock (shares)			6.2			21.5
Aggregate cost of shares repurchased			$ 367,000,000			$ 1,299,000,000
Average price of repurchased shares, per share (usd per share)			$ 59.18			$ 60.40
Stock repurchase program, remaining authorized repurchase amount			$ 700,000,000			$ 700,000,000
Accounting Standards Update 2016-18 [Member]
Equity, Class of Treasury Stock [Line Items]
Restricted cash	$ 61,000,000		$ 99,000,000		61,000,000	$ 99,000,000	61,000,000	$ 61,000,000					$ 82,000,000
Cost of Sales [Member] | Account Standards Update 2017-07 [Member]
Equity, Class of Treasury Stock [Line Items]
Net periodic benefit income, excluding service cost					12,000,000		20,000,000
Marketing, Adminstration and Research Costs [Member] | Account Standards Update 2017-07 [Member]
Equity, Class of Treasury Stock [Line Items]
Net periodic benefit income, excluding service cost					$ 6,000,000		$ 17,000,000
Subsequent Event [Member] | AB InBev [Member]
Equity, Class of Treasury Stock [Line Items]
Fair value of equity investment										$ 14,500,000,000

Background and Basis of Prese_5

Background and Basis of Presentation (Share Repurchase Table) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Total number of shares repurchased (shares)	6.2	11.1	21.8	33.2
Aggregate cost of shares repurchased	$ 367	$ 759	$ 1,317	$ 2,359	$ 2,917
Average price per share of shares repurchased (usd per share)	$ 59.18	$ 67.99	$ 60.53	$ 70.97

Revenues from Contracts with _2

Revenues from Contracts with Customers (Narrative) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Disaggregation of Revenue [Line Items]
Contract duration	1 year
Allowance for sales discounts, goods	$ 0	$ 0
Deferred revenue	$ 116,000,000	267,000,000
Expected period for satisfaction of performance obligation	three days
Receivables	$ 187,000,000	$ 142,000,000
USSTC [Member]
Disaggregation of Revenue [Line Items]
Expected period for satisfaction of performance obligation	one business day
Ste. Michelle [Member]
Disaggregation of Revenue [Line Items]
Expected period for satisfaction of performance obligation	45 days

Investment in AB InBev (Details

Investment in AB InBev (Details) - USD ($) shares in Millions	Oct. 25, 2018	Sep. 30, 2018	Dec. 31, 2017
Schedule of Equity Method Investments [Line Items]
Carrying value of equity investment		$ 17,825,000,000	$ 17,952,000,000
AB InBev [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage		10.10%
Number of restricted shares owned (in shares)		185
Number of ordinary shares owned (in shares)		12
Fair value of equity investment		$ 17,200,000,000	22,100,000,000
Carrying value of equity investment		17,800,000,000	$ 18,000,000,000
Impairment of equity investment		$ 0
Subsequent Event [Member] | AB InBev [Member]
Schedule of Equity Method Investments [Line Items]
Fair value of equity investment	$ 14,500,000,000
Equity Method Investments, Dividend Rate Rebase	50.00%

Benefit Plans (Schedule Of Comp

Benefit Plans (Schedule Of Components Of Net Periodic Benefit Cost (Income)) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Amortization:
Net periodic benefit cost (income)	$ (21)	$ (18)	$ (37)	$ (37)
Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	20	19	61	57
Interest cost	69	72	207	216
Expected return on plan assets	(146)	(151)	(438)	(451)
Amortization:
Net loss	56	49	168	147
Prior service cost (credit)	1	1	3	3
Net periodic benefit cost (income)	0	(10)	1	(28)
Postretirement [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	4	3	13	12
Interest cost	15	17	52	57
Expected return on plan assets	(5)	0	(14)	0
Amortization:
Net loss	(1)	3	16	19
Prior service cost (credit)	(10)	(9)	(31)	(28)
Net periodic benefit cost (income)	$ 3	$ 14	$ 36	$ 60

Benefit Plans (Narrative) (Deta

Benefit Plans (Narrative) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2018USD ($)
Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Additional employer contributions	$ 19
Pension [Member] | Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
Anticipated additional employer contributions	25
Other Postretirement Benefits Plan [Member] | Maximum [Member]
Defined Benefit Plan Disclosure [Line Items]
Anticipated additional employer contributions	$ 70

Earnings Per Share (Basic and D

Earnings Per Share (Basic and Diluted Earnings Per Share) (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Earnings Per Share [Abstract]
Net earnings attributable to Altria	$ 1,943	$ 1,866	$ 5,713	$ 5,256
Less: Distributed and undistributed earnings attributable to share-based awards	(2)	(2)	(7)	(7)
Earnings for basic and diluted EPS	$ 1,941	$ 1,864	$ 5,706	$ 5,249
Weighted-average shares for basic and diluted EPS (shares)	1,883	1,915	1,891	1,927

Other Comprehensive Earnings__3

Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance			$ 15,377
Other comprehensive (losses) earnings before reclassifications	$ (512)	$ (216)	(289)	$ 10
Deferred income taxes	107	75	57	(3)
Other comprehensive (losses) earnings before reclassifications, net of deferred income taxes	(405)	(141)	(232)	7
Amounts reclassified to net earnings	29	51	127	159
Deferred income taxes	(6)	(18)	(32)	(60)
Amounts reclassified to net earnings, net of deferred income taxes	23	33	95	99
Other comprehensive (losses) earnings, net of deferred income taxes	(382)	(108)	(137)	106	$ 155
Ending balance	15,494		15,494		15,377
Benefit Plans [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance	(1,752)	(1,983)	(1,839)	(2,048)	(2,048)
Other comprehensive (losses) earnings before reclassifications	0	0	0	0
Deferred income taxes	0	0	0	0
Other comprehensive (losses) earnings before reclassifications, net of deferred income taxes	0	0	0	0
Amounts reclassified to net earnings	50	48	168	154
Deferred income taxes	(11)	(17)	(42)	(58)
Amounts reclassified to net earnings, net of deferred income taxes	39	31	126	96
Other comprehensive (losses) earnings, net of deferred income taxes	39	31	126	96
Ending balance	(1,713)	(1,952)	(1,713)	(1,952)	(1,839)
AB InBev [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance	106	148	(54)	0	0
Other comprehensive (losses) earnings before reclassifications	(513)	(216)	(288)	9
Deferred income taxes	107	75	57	(3)
Other comprehensive (losses) earnings before reclassifications, net of deferred income taxes	(406)	(141)	(231)	6
Amounts reclassified to net earnings	(21)	3	(41)	5
Deferred income taxes	5	(1)	10	(2)
Amounts reclassified to net earnings, net of deferred income taxes	(16)	2	(31)	3
Other comprehensive (losses) earnings, net of deferred income taxes	(422)	(139)	(262)	9
Ending balance	(316)	9	(316)	9	(54)
Currency Translation Adjustments and Other [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance	(6)	(3)	(4)	(4)	(4)
Other comprehensive (losses) earnings before reclassifications	1	0	(1)	1
Deferred income taxes	0	0	0	0
Other comprehensive (losses) earnings before reclassifications, net of deferred income taxes	1	0	(1)	1
Amounts reclassified to net earnings	0	0	0	0
Deferred income taxes	0	0	0	0
Amounts reclassified to net earnings, net of deferred income taxes	0	0	0	0
Other comprehensive (losses) earnings, net of deferred income taxes	1	0	(1)	1
Ending balance	(5)	(3)	(5)	(3)	(4)
Accumulated Other Comprehensive Losses [Member]
Accumulated Other Comprehensive Income [Roll Forward]
Beginning balance	(1,652)	(1,838)	(1,897)	(2,052)	(2,052)
Other comprehensive (losses) earnings, net of deferred income taxes			(137)		155
Ending balance	$ (2,034)	$ (1,946)	$ (2,034)	$ (1,946)	$ (1,897)

Other Comprehensive Earnings__4

Other Comprehensive Earnings/Losses (Reclassifications) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings	$ 29	$ 51	$ 127	$ 159
AB InBev [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings	(21)	3	(41)	5
Net loss [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings	59	56	196	179
Prior service cost/credit [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings	(9)	(8)	(28)	(25)
Benefit Plans [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings	$ 50	$ 48	$ 168	$ 154

Segment Reporting (Segment Data

Segment Reporting (Segment Data Schedule) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Segment Reporting Information [Line Items]
Net revenues	$ 6,837	$ 6,729	$ 19,250	$ 19,475
Operating income	2,557	2,589	7,371	7,356
Interest and other debt expense, net	(159)	(169)	(503)	(525)
Net periodic benefit income, excluding service cost	21	18	37	37
Earnings from equity investment in AB InBev	189	169	759	332
(Loss) gain on AB InBev/SABMiller business combination	0	37	(33)	445
Earnings before income taxes and equity earnings of subsidiaries	2,608	2,644	7,631	7,645
Smokeable Products [Member]
Segment Reporting Information [Line Items]
Net revenues	6,035	5,975	16,995	17,355
Smokeless Products [Member]
Segment Reporting Information [Line Items]
Net revenues	586	550	1,690	1,580
Wine [Member]
Segment Reporting Information [Line Items]
Net revenues	181	181	489	471
All Other [Member]
Segment Reporting Information [Line Items]
Net revenues	35	23	76	69
Operating Segments [Member] | Smokeable Products [Member]
Segment Reporting Information [Line Items]
Operating income	2,277	2,276	6,516	6,536
Operating Segments [Member] | Smokeless Products [Member]
Segment Reporting Information [Line Items]
Operating income	370	348	1,085	941
Operating Segments [Member] | Wine [Member]
Segment Reporting Information [Line Items]
Operating income	29	36	73	82
Operating Segments [Member] | All Other [Member]
Segment Reporting Information [Line Items]
Operating income	(38)	(10)	(121)	(31)
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Amortization of intangibles	(20)	(5)	(30)	(15)
General corporate [Member]
Segment Reporting Information [Line Items]
General corporate expenses	$ (61)	$ (56)	$ (152)	$ (157)

Segment Reporting (Schedule of

Segment Reporting (Schedule of Pre-tax Tobacco and Health Litigation Items) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Non-Participating Manufacturer Arbitration Panel Decision [Member]
Segment Reporting Information [Line Items]
Pre-tax (income) expense for NPM adjustment items	$ 0	$ 5	$ (145)	$ 4
PM USA [Member] | Tobacco and Health Litigation Cases [Member]
Segment Reporting Information [Line Items]
Provision related to litigation recorded	21	0	119	18
PM USA [Member] | Non-Participating Manufacturer Arbitration Panel Decision [Member] | Interest And Other Debt Expense, Net [Member]
Segment Reporting Information [Line Items]
Interest and other debt expense, net	0	2	0	9
NPM Adjustment to Cost Of Sales [Member] | PM USA [Member] | Smokeable Products [Member] | Non-Participating Manufacturer Arbitration Panel Decision [Member] | Cost of Sales [Member]
Segment Reporting Information [Line Items]
Pre-tax (income) expense for NPM adjustment items	0	3	(145)	(5)
Operating Segments [Member] | PM USA [Member] | Smokeable Products [Member] | Tobacco and Health Litigation Cases [Member] | Operating Income (Loss) [Member]
Segment Reporting Information [Line Items]
Provision related to litigation recorded	$ 10	$ 0	$ 94	$ 16

Segment Reporting Schedule of T

Segment Reporting Schedule of Tobacco and Health Litigation Items (Details) - PM USA [Member] - Tobacco and Health Litigation Cases [Member] - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]
Provision related to litigation recorded	$ 21	$ 0	$ 119	$ 18
Operating Income (Loss) [Member] | Operating Segments [Member] | Smokeable Products [Member]
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]
Provision related to litigation recorded	10	0	94	16
Operating Income (Loss) [Member] | Operating Segments [Member] | Smokeless Products [Member]
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]
Provision related to litigation recorded	10	0	10	0
Interest And Other Debt Expense, Net [Member] | Segment Reconciling Items [Member]
Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]
Provision related to litigation recorded	$ 1	$ 0	$ 15	$ 2

Segment Reporting (Narrative) (

Segment Reporting (Narrative) (Details) $ in Millions	3 Months Ended
	Mar. 31, 2017USD ($)
Operating Segments [Member] | Smokeless Products [Member]
Segment Reporting Information [Line Items]
Recall impact on operating income	$ 60

Segment Reporting (Pre-tax Asse

Segment Reporting (Pre-tax Asset Impairment, Exit and Implementation Costs) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Segment Reporting Information [Line Items]
Asset Impairment and Exit Costs	$ (2)	$ 8	$ 2	$ 24
Implementation Costs	(1)	7	4	47
Total	(3)	15	6	71
Operating Segments [Member] | Smokeable Products [Member]
Segment Reporting Information [Line Items]
Asset Impairment and Exit Costs	(5)	0	(4)	2
Implementation Costs	(1)	5	1	17
Total	(6)	5	(3)	19
Operating Segments [Member] | Smokeless Products [Member]
Segment Reporting Information [Line Items]
Asset Impairment and Exit Costs	3	8	6	22
Implementation Costs	0	2	3	30
Total	$ 3	$ 10	$ 9	$ 52

Debt (Narrative) (Details)

Debt (Narrative) (Details)	Aug. 01, 2018USD ($)Extension	Sep. 30, 2018USD ($)	Dec. 31, 2017USD ($)
Debt Instrument [Line Items]
Short-term borrowings		$ 0	$ 0
Accrued interest on long-term debt		155,000,000	219,000,000
Reported Value Measurement [Member]
Debt Instrument [Line Items]
Long-term debt		13,900,000,000	13,900,000,000
Fair Value, Inputs, Level 2 [Member] | Estimate of Fair Value Measurement [Member]
Debt Instrument [Line Items]
Long-term debt		14,200,000,000	$ 15,300,000,000
Revolving Credit Facility [Member] | Revolving Credit Facility Due August 2023 [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Agreement term	5 years
Credit line available under the agreement	$ 3,000,000,000
Number of extensions | Extension	2
Extension term	1 year
Minimum consolidated EBITDA to interest expense	4
Consolidated EBITDA to interest expense	14.8
Revolving Credit Facility [Member] | Revolving Credit Facility Due August 2020 [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Agreement term	5 years
Credit line available under the agreement	$ 3,000,000,000
LIBOR [Member] | Revolving Credit Facility [Member] | Revolving Credit Facility Due August 2023 [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Applicable interest	1.00%
Credit available under credit agreement		$ 3,000,000,000

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2018USD ($)	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2017USD ($)	Dec. 31, 2017USD ($)
Income Tax Disclosure [Abstract]
Income tax rate	25.50%			25.10%
Decrease in income tax percentage	0.039			0.061
Tax expense for reserves related to the calculation of certain foreign tax credits			$ 114		$ 114
Tax benefit for release of valuation allowance related to deferred income tax assets		$ 232			232
Tax benefits related to effective settlement of IRS audit					152
Tax expense from partial reversal of the tax basis benefit associated with deemed repatriation tax	$ 40			$ 122
Tax expense for valuation allowance on foreign tax credit carryforwards that are not realizable as a result of updates to provisional estimates recorded for the Tax Reform Act	17			51
Tax benefits for the reversal of tax accruals no longer required		$ 36			$ 36
Tax Reform Act, net tax expense (benefit)	(1)			1
Unrecognized tax benefits	(34)			(34)		$ 66
Unrecognized tax benefits that would impact the effective tax rate	58			58		43
Unrecognized tax benefits that would impact deferred taxes	(92)			(92)		$ 23
Possible decrease in unrecognized tax benefits	$ (75)			$ (75)

Contingencies (General Informat

Contingencies (General Information) (Details)	Sep. 30, 2018state
Commitments and Contingencies Disclosure [Abstract]
Number of states that cap bond or require no bond	47

Contingencies (Schedule Of Pend

Contingencies (Schedule Of Pending Cases) (Details)	Oct. 22, 2018case	Mar. 31, 2018case	Oct. 23, 2017casetrialplantiff	Sep. 30, 2018case	Oct. 24, 2016case
Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of cases pending			87		66
ETS Smoking and Health Case, Flight Attendants [Member] | Pending Litigation [Member]
Loss Contingencies [Line Items]
Number of claims dismissed		923
Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of cases pending			4		5
Smoking And Health Class Actions And Aggregated Claims Litigation [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed				61
Smoking And Health Class Actions And Aggregated Claims Litigation [Member] | FLORIDA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed				2
Smoking And Health Class Actions And Aggregated Claims Litigation [Member] | Pending Litigation [Member] | WEST VIRGINIA [Member]
Loss Contingencies [Line Items]
Number of cases			30
Number of plaintiffs | plantiff			30
Number of consolidated trials | trial			6
Smoking And Health Class Actions And Aggregated Claims Litigation [Member] | Pending Litigation [Member] | WEST VIRGINIA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of cases			9
Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending			1		1
Lights Ultra Lights Class Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending			4		9
Subsequent Event [Member] | Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of cases pending	101
Subsequent Event [Member] | Individual Smoking And Health Cases [Member] | MASSACHUSETTS [Member]
Loss Contingencies [Line Items]
Number of cases pending	29
Subsequent Event [Member] | Individual Smoking And Health Cases [Member] | FLORIDA [Member]
Loss Contingencies [Line Items]
Number of cases pending	38
Subsequent Event [Member] | ETS Smoking and Health Case, Flight Attendants [Member] | Pending Litigation [Member]
Loss Contingencies [Line Items]
Number of cases	1,491
Subsequent Event [Member] | Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of cases pending	2
Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending	1
Subsequent Event [Member] | Lights Ultra Lights Class Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending	2

Contingencies (Overview of Altr

Contingencies (Overview of Altria and/or PM USA Tobacco-Related Litigation Narrative) (Details) - case	Oct. 22, 2018	Oct. 22, 2018	Oct. 23, 2017	Oct. 24, 2016
Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending			1	1
Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of cases pending			4	5
Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of cases pending			87	66
Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending	1	1
Subsequent Event [Member] | Smoking And Health Class Actions And Aggregated Claims Litigation [Member]
Loss Contingencies [Line Items]
Number of cases pending	2	2
Subsequent Event [Member] | Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of cases pending	101	101
Subsequent Event [Member] | Individual Smoking And Health Cases [Member] | FLORIDA [Member]
Loss Contingencies [Line Items]
Number of cases pending	38	38
Subsequent Event [Member] | Individual Smoking And Health Cases [Member] | MASSACHUSETTS [Member]
Loss Contingencies [Line Items]
Number of cases pending	29	29
Subsequent Event [Member] | PM USA [Member] | Health Care Cost Recovery Actions [Member] | CANADA [Member]
Loss Contingencies [Line Items]
Number of cases pending	10	10
Subsequent Event [Member] | PM USA [Member] | Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of cases set for trial	5	5
Number of verdicts returned	124
Number of favorable verdicts	44
Number of unfavorable verdicts	68
Subsequent Event [Member] | PM USA [Member] | Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Number of cases set for trial	2	2
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Number of verdicts returned		64
Number of favorable verdicts		43
Number of unfavorable verdicts		21
Number of claims resolved		19
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | ALASKA [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		1
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | CALIFORNIA [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		7
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | CONNECTICUT [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		1
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | FLORIDA [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		10
Number cases with granted new trial	1	1
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | LOUISIANA [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		1
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | MASSACHUSETTS [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		3
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | MISSISSIPPI [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		1
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | MISSOURI [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		4
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | NEW HAMPSHIRE [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		1
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | NEW JERSEY [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		1
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | NEW YORK [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		5
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | OHIO [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		2
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | PENNSYLVANIA [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		1
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | RHODE ISLAND [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		1
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | TENNESSEE [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		2
Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | WEST VIRGINIA [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts		2
Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Health Care Cost Recovery Actions [Member] | CANADA [Member]
Loss Contingencies [Line Items]
Number of cases pending	8	8
Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Smoking And Health Class Actions And Aggregated Claims Litigation [Member] | CANADA [Member]
Loss Contingencies [Line Items]
Number of cases pending	7	7

Contingencies (Judgments Paid a

Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended		12 Months Ended	168 Months Ended
	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2015	Sep. 30, 2018
Loss Contingency Accrual [Roll Forward]
Accrued liability for tobacco and health litigation items at beginning of period	$ 107	$ 47	$ 47	$ 106	$ 47
Payments	(21)		0	(118)	(18)
Accrued liability for tobacco and health litigation items at end of period	107	$ 106	47	107	47		$ 107
Interest Expense Related To Litigation [Member]
Loss Contingency Accrual [Roll Forward]
Pre-tax charges	1		0	15	2
Tobacco and Health Judgment [Member]
Loss Contingencies [Line Items]
Judgments paid (approximately)							578
Litigation settlement interest expense (income)							195
Tobacco and Health Judgment [Member] | Litigation Cases Results [Member]
Loss Contingency Accrual [Roll Forward]
Pre-tax charges	20		$ 0	104	$ 16
Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Judgments paid (approximately)							186
Litigation settlement interest expense (income)							33
PM USA [Member] | Engle Progeny Cases, Federal [Member]
Loss Contingencies [Line Items]
Payments made							43
Loss Contingency Accrual [Roll Forward]
Payments						$ (43)
Assets [Member] | Pending Litigation [Member] | PM USA [Member]
Loss Contingency Accrual [Roll Forward]
Security posted for appeal of judgments	$ 99			$ 99			$ 99

Contingencies (Non-Engle Progen

Contingencies (Non-Engle Progeny Litigation) (Details) - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2017	Apr. 30, 2018	Oct. 31, 2017	Dec. 31, 2015
Non-Engle Progeny Smoking and Health Case, Gentile [Member]
Loss Contingencies [Line Items]
Compensatory damages awarded			$ 7,100
Non-Engle Progeny Smoking and Health Case, Gentile [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Compensatory damages awarded			$ 5,300
Compensatory damages award, allocation percentage			75.00%
Appeal bond posted		$ 8,000
Non-Engle Progeny Smoking and Health Case, Bullock [Member]
Loss Contingencies [Line Items]
Compensatory damages awarded				$ 900
Non-Engle Progeny Smoking and Health Case, Bullock [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Provision related to litigation recorded	$ 1,000

Contingencies (Engle Class Acti

Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)	Oct. 22, 2018USD ($)caseplantiff	Feb. 29, 2008USD ($)	Jul. 31, 2006USD ($)plantiff	Sep. 30, 2018USD ($)	Sep. 30, 2017USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2017USD ($)	Dec. 31, 2015USD ($)case	Jul. 31, 2000USD ($)
Loss Contingencies [Line Items]
Payments made related to litigation | $				$ 21,000,000	$ 0	$ 118,000,000	$ 18,000,000
Engle Progeny Cases [Member]
Loss Contingencies [Line Items]
Punitive damages awarded | $									$ 145,000,000,000
Engle Progeny Cases [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Punitive damages awarded | $									$ 74,000,000,000
Period for decertified class members could file individual actions			1 year
Engle Progeny Cases, Federal [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Payments made related to litigation | $								$ 43,000,000
Number of claims resolved								415
FLORIDA [Member] | Engle Progeny Cases, State [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Compensatory damages awarded | $			$ 6,900,000
Number individual plaintiffs reinstated | plantiff			2
Payments made related to litigation | $		$ 3,000,000
Subsequent Event [Member] | Engle Progeny Cases [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of verdicts returned	124
Number of unfavorable verdicts	68
Number of claims with unfavorable verdicts pending/reversed	8
Number of favorable verdicts	44
Subsequent Event [Member] | Engle Progeny Cases, State [Member]
Loss Contingencies [Line Items]
Number of plaintiffs | plantiff	3,000
Number of cases pending	2,200
Subsequent Event [Member] | Engle Progeny Cases, State [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of favorable verdicts	37
Subsequent Event [Member] | Engle Progeny Cases, Federal [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of cases pending	7
Subsequent Event [Member] | Engle Progeny Cases, D. Cohen, Collar, Chacon and Starbuck [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of verdicts reversed	4
Subsequent Event [Member] | Engle Progeny Cases, Reider and Banks [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Damages awarded, value | $	$ 0
Subsequent Event [Member] | Engle Progeny Cases, Weingart and Hancock [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Damages awarded, value | $	$ 0

Contingencies (Engle Progeny Ca

Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details) - USD ($)

Oct. 22, 2018

Sep. 30, 2018

Aug. 31, 2018

May 31, 2018

Jan. 31, 2018

Sep. 30, 2018

Jun. 30, 2018

Mar. 31, 2018

Dec. 31, 2017

Sep. 30, 2017

Jun. 30, 2017

Mar. 31, 2016

Sep. 30, 2018

Sep. 30, 2017

Oct. 31, 2018

Jul. 31, 2018

Feb. 28, 2018

Nov. 30, 2017

Oct. 31, 2017

Aug. 31, 2017

May 31, 2017

Apr. 30, 2017

Mar. 31, 2017

Feb. 28, 2017

Dec. 31, 2016

Nov. 30, 2016

Sep. 30, 2016

Jul. 31, 2016

Apr. 30, 2016

Feb. 29, 2016

Jan. 31, 2016

Dec. 31, 2015

Nov. 30, 2015

Oct. 31, 2015

Sep. 30, 2015

Aug. 31, 2015

Jul. 31, 2015

Jun. 30, 2015

May 31, 2015

Mar. 31, 2015

Feb. 28, 2015

Jan. 31, 2015

Nov. 30, 2014

Oct. 31, 2014

Sep. 30, 2014

Jul. 31, 2014

Jun. 30, 2014

May 31, 2014

Dec. 31, 2013

Oct. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

May 31, 2013

Apr. 30, 2013

Sep. 30, 2012

Aug. 31, 2012

Jun. 30, 2012

May 31, 2012

Dec. 31, 2011

Apr. 30, 2010

Nov. 30, 2009

Loss Contingencies [Line Items]

Accrual related to litigation recorded

$ 107,000,000

$ 107,000,000

$ 107,000,000

$ 106,000,000

$ 47,000,000

$ 47,000,000

$ 107,000,000

$ 47,000,000

$ 47,000,000

Payments made related to litigation

21,000,000

0

118,000,000

18,000,000

Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

2,400,000

2,400,000

2,400,000

Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 2,100,000

Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

2,300,000

Appeal bond posted

3,000,000

3,000,000

3,000,000

Engle Progeny Cases, Landi [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

8,000,000

Engle Progeny Cases, Landi [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

5,000,000

Appeal bond posted

$ 2,000,000

Engle Progeny Cases, Theis [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 7,000,000

Engle Progeny Cases, Theis [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

10,000,000

Appeal bond posted

3,000,000

Engle Progeny Cases, Freeman [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 4,000,000

Appeal bond posted

4,000,000

Engle Progeny Cases, Gloger [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 7,500,000

Engle Progeny Cases, Gloger [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

5,000,000

Appeal bond posted

3,000,000

Engle Progeny Cases, Bryant [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

581,000

Engle Progeny Cases, Bryant [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

225,000

Appeal bond posted

1,000,000

Engle Progeny Cases, R. Douglas [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 131,371

Engle Progeny Cases, R. Douglas [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 5,255

Compensatory damages award, allocation percentage

4.00%

Engle Progeny Cases, Wallace [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 12,000,000

Engle Progeny Cases, Wallace [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 16,000,000

Appeal bond posted

3,000,000

Engle Progeny Cases, L. Martin [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 1,100,000

Engle Progeny Cases, L. Martin [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

605,000

Punitive damages awarded

$ 1,300,000

Appeal bond posted

$ 2,000,000

Compensatory damages award, allocation percentage

55.00%

Engle Progeny Cases, Sommers [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 1,000,000

Appeal bond posted

1,000,000

Engle Progeny Cases, Santoro [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 1,600,000

Engle Progeny Cases, Santoro [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 100,000

Appeal bond posted

1,000,000

Engle Progeny Cases, J. Brown [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 5,400,000

Engle Progeny Cases, J. Brown [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

200,000

Appeal bond posted

$ 3,000,000

$ 3,000,000

Engle Progeny Cases, Pardue [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

5,200,000

5,900,000

Engle Progeny Cases, Pardue [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 6,750,000

Appeal bond posted

$ 3,000,000

Provision related to litigation recorded

9,000,000

Increase in appeal bond

5,000,000

Engle Progeny Cases, S. Martin [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 5,400,000

Engle Progeny Cases, S. Martin [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

2,480,000

Punitive damages awarded

$ 450,000

Appeal bond posted

$ 3,000,000

Compensatory damages award, allocation percentage

46.00%

Engle Progeny Cases, Oshinsky-Blacker [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 6,155,000

Engle Progeny Cases, Oshinsky-Blacker [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

3,700,000

Punitive damages awarded

$ 1,000,000

Compensatory damages award, allocation percentage

60.00%

Engle Progeny Cases, McCall [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 350,000

Engle Progeny Cases, McCall [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 87,500

Compensatory damages award, allocation percentage

25.00%

Engle Progeny Cases, Danielson [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

2,600,000

2,600,000

2,600,000

$ 325,000

Punitive damages awarded

325,000

325,000

325,000

325,000

Economic damages sought

2,300,000

Non-economic compensatory damages awarded

250,000

250,000

250,000

Engle Progeny Cases, Duignan [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 6,000,000

Engle Progeny Cases, Duignan [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

3,500,000

Appeal bond posted

3,000,000

Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

4,500,000

Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 300,000

$ 450,000

Appeal bond posted

$ 300,000

Compensatory damages award, allocation percentage

10.00%

Engle Progeny Cases, Jordan [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 7,800,000

Punitive damages awarded

3,200,000

Appeal bond posted

10,000,000

Provision related to litigation recorded

11,000,000

Reduced compensatory damages

$ 6,400,000

Engle Progeny Cases, McCoy [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 1,500,000

Engle Progeny Cases, McCoy [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

300,000

Punitive damages awarded

$ 3,000,000

Appeal bond posted

$ 2,000,000

Compensatory damages award, allocation percentage

20.00%

Engle Progeny Cases, M. Brown [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 6,375,000

Appeal bond posted

$ 5,000,000

Provision related to litigation recorded

7,000,000

Increase in appeal bond

1,000,000

Engle Progeny Cases, Pollari [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 10,000,000

Engle Progeny Cases, Pollari [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

4,250,000

Punitive damages awarded

$ 1,500,000

Appeal bond posted

3,000,000

Compensatory damages award, allocation percentage

42.50%

Engle Progeny Cases, Caprio [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Economic damages awarded

$ 559,172

Engle Progeny Cases, Caprio [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages award, allocation percentage

25.00%

Engle Progeny Cases, McKeever [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 5,800,000

Engle Progeny Cases, McKeever [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 11,630,000

Appeal bond posted

$ 5,000,000

Compensatory damages award, allocation percentage

60.00%

Provision related to litigation recorded

20,000,000

Increase in appeal bond

10,000,000

Accrual related to litigation recorded

17,000,000

Engle Progeny Cases, D. Brown [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 8,300,000

Punitive damages awarded

$ 9,000,000

Engle Progeny Cases, Boatright [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 15,000,000

Punitive damages awarded against co-defendant

300,000

Engle Progeny Cases, Boatright [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

12,750,000

Punitive damages awarded

$ 19,700,000

Appeal bond posted

$ 4,000,000

Compensatory damages award, allocation percentage

85.00%

Provision related to litigation recorded

$ 41,000,000

Increase in appeal bond

$ 11,000,000

Engle Progeny Cases, Kerrivan [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 15,800,000

Punitive damages awarded

25,300,000

Engle Progeny Cases, Kerrivan [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

15,700,000

Engle Progeny Cases, Berger [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 6,250,000

Engle Progeny Cases, Berger [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 20,760,000

Compensatory damages award, allocation percentage

60.00%

Engle Progeny Cases, Harris [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 1,730,000

Engle Progeny Cases, Skolnick [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 2,555,000

Engle Progeny Cases, Skolnick [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 766,500

Appeal bond posted

$ 1,000,000

Compensatory damages award, allocation percentage

30.00%

Engle Progeny Cases, Searcy [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 1,000,000

$ 6,000,000

Engle Progeny Cases, Searcy [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 1,670,000

$ 10,000,000

Appeal bond posted

$ 2,000,000

Provision related to litigation recorded

2,000,000

Engle Progeny Cases, Calloway [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 16,100,000

$ 21,000,000

Engle Progeny Cases, Calloway [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 4,025,000

Punitive damages awarded

17,000,000

Appeal bond posted

$ 2,000,000

Engle Progeny Cases, Calloway [Member] | Pending Litigation [Member] | R.J. Reynolds [Member]

Loss Contingencies [Line Items]

Punitive damages awarded against co-defendant

17,000,000

Engle Progeny Cases, Calloway [Member] | Pending Litigation [Member] | Lorillard [Member]

Loss Contingencies [Line Items]

Punitive damages awarded against co-defendant

13,000,000

Engle Progeny Cases, Calloway [Member] | Pending Litigation [Member] | Liggett Group [Member]

Loss Contingencies [Line Items]

Punitive damages awarded against co-defendant

$ 8,000,000

Engle Progeny Cases, Simon [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

1,000,000

1,000,000

1,000,000

Engle Progeny Cases, Simon [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 200,000

$ 200,000

$ 200,000

Compensatory damages award, allocation percentage

20.00%

20.00%

20.00%

Engle Progeny Cases, Perrotto [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 4,100,000

Engle Progeny Cases, Perrotto [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 1,000,000

Compensatory damages award, allocation percentage

25.00%

Engle Progeny Cases, Perrotto [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 1,000,000

Payments made related to litigation

$ 1,000,000

Engle Progeny Cases, Gore [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 2,000,000

Engle Progeny Cases, Gore [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Provision related to litigation recorded

1,000,000

Engle Progeny Cases, Gore [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

$ 1,000,000

Engle Progeny Cases, Putney [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 225,000

$ 15,100,000

Engle Progeny Cases, Putney [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

2,300,000

Punitive damages awarded

$ 2,500,000

Compensatory damages award, allocation percentage

15.00%

Provision related to litigation recorded

$ 5,000,000

Engle Progeny Cases, Sermons [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 65,000

Engle Progeny Cases, Sermons [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

9,750

Punitive damages awarded

$ 51,225

Compensatory damages award, allocation percentage

15.00%

Engle Progeny Cases, Sermons [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

$ 118,000

Engle Progeny Cases, Tognoli [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

1,050,000

Engle Progeny Cases, Tognoli [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 157,500

Compensatory damages award, allocation percentage

15.00%

Provision for judgment plus interest and associated costs

1,000,000

Engle Progeny Cases, Tognoli [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

1,000,000

Engle Progeny Cases, Howles [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 4,000,000

Engle Progeny Cases, Howles [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

2,000,000

Punitive damages awarded

$ 3,000,000

Compensatory damages award, allocation percentage

50.00%

Provision for judgment plus interest and associated costs

6,000,000

Engle Progeny Cases, Purdo [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 21,000,000

Engle Progeny Cases, Purdo [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

2,520,000

Punitive damages awarded

$ 6,250,000

Compensatory damages award, allocation percentage

12.00%

Provision for judgment plus interest and associated costs

10,000,000

Engle Progeny Cases, Purdo [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

10,000,000

Engle Progeny Cases, Griffin [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 1,270,000

Engle Progeny Cases, Griffin [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 630,000

Compensatory damages award, allocation percentage

50.00%

Provision related to litigation recorded

1,000,000

Engle Progeny Cases, Griffin [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

1,000,000

Engle Progeny Cases, Ledoux [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 10,000,000

Engle Progeny Cases, Ledoux [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 12,500,000

Appeal bond posted

3,000,000

Provision for judgment plus interest and associated costs

20,000,000

Engle Progeny Cases, Ledoux [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

20,000,000

Engle Progeny Cases, Burkhart [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 5,000,000

Punitive damages awarded

2,500,000

Engle Progeny Cases, Burkhart [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 750,000

Engle Progeny Cases, Burkhart [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Provision related to litigation recorded

2,000,000

Engle Progeny Cases, Barbose [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 10,000,000

Punitive damages awarded

$ 500,000

Engle Progeny Cases, Barbose [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Provision for judgment plus interest and associated costs

12,000,000

Engle Progeny Cases, Barbose [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

12,000,000

Engle Progeny Cases, Allen [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 3,100,000

$ 6,000,000

Engle Progeny Cases, Allen [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 7,760,000

$ 17,000,000

Provision for judgment plus interest and associated costs

10,000,000

Engle Progeny Cases, Allen [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

10,000,000

Engle Progeny Cases, Ahrens [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

9,000,000

Engle Progeny Cases, Ahrens [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Punitive damages awarded

$ 2,500,000

Provision for judgment plus interest and associated costs

7,000,000

Engle Progeny Cases, Ahrens [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

$ 7,000,000

Engle Progeny Cases, Starr-Blundell [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 500,000

Engle Progeny Cases, Starr-Blundell [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 50,000

Compensatory damages award, allocation percentage

10.00%

Provision related to litigation recorded

$ 55,000

Provision for judgment plus interest and associated costs

40,000

Engle Progeny Cases, Starr-Blundell [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

100,000

Engle Progeny Cases, Zamboni [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

340,000

Engle Progeny Cases, Zamboni [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 34,000

Compensatory damages award, allocation percentage

10.00%

Provision related to litigation recorded

$ 34,000

Engle Progeny Cases, Graham [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 2,750,000

Engle Progeny Cases, Graham [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 275,000

Compensatory damages award, allocation percentage

10.00%

Provision related to litigation recorded

500,000

Engle Progeny Cases, Graham [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

$ 1,000,000

Engle Progeny Cases, Naugle [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 3,700,000

$ 12,300,000

$ 56,600,000

Punitive damages awarded

$ 7,500,000

$ 24,500,000

$ 244,000,000

Engle Progeny Cases, Naugle [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages award, allocation percentage

90.00%

Provision related to litigation recorded

13,200,000

Engle Progeny Cases, Naugle [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

14,000,000

Engle Progeny Cases, Lourie [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

1,370,000

Engle Progeny Cases, Lourie [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 370,000

Compensatory damages award, allocation percentage

27.00%

Provision related to litigation recorded

$ 2,000,000

Engle Progeny Cases, Lourie [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

$ 3,000,000

Engle Progeny Cases, Marchese [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 1,000,000

Punitive damages awarded

250,000

Engle Progeny Cases, Marchese [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded

$ 225,000

Compensatory damages award, allocation percentage

22.50%

Payments made related to litigation

$ 1,000,000

Subsequent Event [Member] | Engle Progeny Cases, Danielson [Member] | Pending Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Appeal bond posted

$ 3,000,000

Subsequent Event [Member] | Engle Progeny Cases, Simon [Member] | Settled Litigation [Member] | PM USA [Member]

Loss Contingencies [Line Items]

Payments made related to litigation

$ 200,000

Contingencies (Florida Bond Sta

Contingencies (Florida Bond Statute) (Details) - Engle Progeny Cases, State [Member]	1 Months Ended
	Jun. 30, 2009USD ($)case
Florida [Member]
Loss Contingencies [Line Items]
Maximum bond required by all defendants | $	$ 200,000,000
Alachua County, Florida [Member]
Loss Contingencies [Line Items]
Number of cases in which plaintiffs that challenged constitutionality of bond cap statute	3
Escambia County, Florida [Member]
Loss Contingencies [Line Items]
Number of cases in which plaintiffs that challenged constitutionality of bond cap statute	1

Contingencies (Other Smoking an

Contingencies (Other Smoking and Health Class Actions) (Details) - Smoking And Health Class Actions And Aggregated Claims Litigation [Member] - case	269 Months Ended
	Sep. 30, 2018	Oct. 22, 2018	Oct. 23, 2017	Oct. 24, 2016
Loss Contingencies [Line Items]
Number of cases pending			4	5
PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	61
ARKANSAS [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
CALIFORNIA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
DELAWARE [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
DISTRICT OF COLUMBIA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	2
Florida [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	2
ILLINOIS [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	3
IOWA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
KANSAS [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
LOUISIANA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
MARYLAND [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
MICHIGAN [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
MINNESOTA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
NEVADA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	29
NEW JERSEY [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	6
NEW YORK [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	2
OHIO [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
OKLAHOMA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
OREGON [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
PENNSYLVANIA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
PUERTO RICO [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
SOUTH CAROLINA [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
TEXAS [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
WISCONSIN [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of claims dismissed	1
Subsequent Event [Member]
Loss Contingencies [Line Items]
Number of cases pending		2
Subsequent Event [Member] | CANADA [Member] | Philip Morris USA and Altria Group [Member]
Loss Contingencies [Line Items]
Number of cases pending		7
Subsequent Event [Member] | BRITISH COLUMBIA [Member] | Philip Morris USA and Altria Group [Member]
Loss Contingencies [Line Items]
Number of cases pending		2

Contingencies (Health Care Cost

Contingencies (Health Care Cost Recovery Litigation) (Details) - Health Care Cost Recovery Actions [Member]	1 Months Ended	3 Months Ended		9 Months Ended
	Nov. 30, 1998USD ($)state	Sep. 30, 2018USD ($)case	Sep. 30, 2017USD ($)	Sep. 30, 2018USD ($)case	Sep. 30, 2017USD ($)	Oct. 23, 2017case	Oct. 24, 2016case
Loss Contingencies [Line Items]
Number of cases pending | case						1	1
Number of states with settled litigation | state	46
State settlement agreements annual payments	$ 9,400,000,000
State settlement agreements attorney fees annual cap	$ 500,000,000
Litigation settlement		$ 1,200,000,000	$ 1,100,000,000	$ 3,200,000,000	$ 3,400,000,000
Threatened Litigation [Member] | Canada [Member]
Loss Contingencies [Line Items]
Number of cases pending | case		10		10

Contingencies (NPM Adjustment D

Contingencies (NPM Adjustment Disputes - Settlement with 35 States and Territories and Settlement with New York) (Details) $ in Millions

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

Apr. 30, 2018USD ($)

Oct. 31, 2017USD ($)state

Sep. 30, 2013USD ($)state

Nov. 30, 1998state

Sep. 30, 2018USD ($)

Jun. 30, 2018USD ($)state

Mar. 31, 2018USD ($)state

Sep. 30, 2017USD ($)

Sep. 30, 2018USD ($)stateclaim

Sep. 30, 2017USD ($)

Dec. 31, 2015USD ($)

Dec. 31, 2012state

Health Care Cost Recovery Actions [Member]

Loss Contingencies [Line Items]

Number of states with settled litigation | state

46

Litigation settlement

$ 1,200

$ 1,100

$ 3,200

$ 3,400

PM USA [Member] | Health Care Cost Recovery Actions [Member]

Loss Contingencies [Line Items]

Loss contingency, number of states | state

52

Loss contingency, reduction to cost of sales

$ 90

$ 81

PM USA [Member] | Health Care Cost Recovery Actions [Member] | Settled Litigation [Member]

Loss Contingencies [Line Items]

Number of claims resolved | claim

2

Number of states with settled litigation | state

37

Loss contingency, number of states with settled litigation including new york | state

19

Loss contingency, number of states with settled litigation including New York, subsequent expansion | state

36

Litigation settlement

$ 217

PM USA [Member] | Health Care Cost Recovery Actions, 2003-2015 NPM Adjustments [Member] | Settled Litigation [Member]

Loss Contingencies [Line Items]

Loss contingency, number of states with settled litigation including New York, subsequent expansion | state

26

Litigation settlement

$ 740

PM USA [Member] | Health Care Cost Recovery Actions, 2004-2017 [Member] | Settled Litigation [Member]

Loss Contingencies [Line Items]

Loss contingency, number of additional states added | state

9

Litigation settlement

90

$ 81

Payments received from litigation settlement

$ 68

PM USA [Member] | Health Care Cost Recovery Actions, 2015-2017 Transition Years [Member] | Settled Litigation [Member]

Loss Contingencies [Line Items]

Litigation settlement

13

$ 13

PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Settled Litigation [Member]

Loss Contingencies [Line Items]

Number of states with settled litigation | state

2

PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Loss contingency, number of states | state

15

Number of states that did not diligently enforcing escrow statutes | state

6

Loss contingency, number of states remaining | state

4

Loss contingency, number of disputes outstanding | state

2

PM USA [Member] | Health Care Cost Recovery Actions, 2003 NPM Adjustment [Member] | Pending Litigation [Member] | Cost of Sales [Member]

Loss Contingencies [Line Items]

Litigation settlement

$ 74

PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

$ 388

PM USA [Member] | Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

181

PM USA [Member] | Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

154

PM USA [Member] | Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

185

PM USA [Member] | Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

250

PM USA [Member] | Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

211

PM USA [Member] | Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

218

PM USA [Member] | Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

166

PM USA [Member] | Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

214

PM USA [Member] | Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

224

PM USA [Member] | Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

253

PM USA [Member] | Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]

Loss Contingencies [Line Items]

Estimate of possible gain

300

PM USA [Member] | Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]

Loss Contingencies [Line Items]

Loss contingency, reduction to cost of sales

$ 39

Estimate of possible gain

295

PM USA [Member] | Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]

Loss Contingencies [Line Items]

Loss contingency, reduction to cost of sales

$ 38

Estimate of possible gain

$ 288

PM USA [Member] | Health Care Cost Recovery Actions, 2016 and 2017 NPM Adjustments [Member] | Settled Litigation [Member]

Loss Contingencies [Line Items]

Loss contingency, number of states with settled litigation including New York, subsequent expansion | state

26

Litigation settlement

$ 77

Contingencies (Other Disputes U

Contingencies (Other Disputes Under the State Settlement Agreements) (Details) $ in Millions	1 Months Ended
	Aug. 31, 2018USD ($)
PM USA [Member] | Other Disputes Under the State Settlement Agreements [Member]
Loss Contingencies [Line Items]
Amount ordered to be paid from other party	$ 9.8

Contingencies (Federal Governme

Contingencies (Federal Government's Lawsuit) (Details) - Federal Governments Lawsuit [Member] - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Aug. 31, 2006	Jun. 30, 2014
Loss Contingencies [Line Items]
Disclosure period	10 years
Implementation of Corrective Communications [Member]
Loss Contingencies [Line Items]
Provision related to litigation recorded		$ 31

Contingencies (Lights_Ultra Lig

Contingencies (Lights/Ultra Lights Cases) (Details)	Oct. 22, 2018casecourt	Oct. 23, 2017case	Oct. 24, 2016case
Lights Ultra Lights Class Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending		4	9
Subsequent Event [Member] | Lights Ultra Lights Class Actions [Member]
Loss Contingencies [Line Items]
Number of cases pending	2
Subsequent Event [Member] | Lights [Member]
Loss Contingencies [Line Items]
Claims not certified, number	23
Subsequent Event [Member] | Lights [Member] | PM USA [Member]
Loss Contingencies [Line Items]
Number of state courts | court	21

Contingencies (UST Litigations

Contingencies (UST Litigations Narrative) (Details)	Jul. 31, 2016case
CALIFORNIA [Member] | UST Litigation [Member]
Loss Contingencies [Line Items]
Number of cases pending	1

Contingencies (Guarantees and O

Contingencies (Guarantees and Other Similar Matters Narrative) (Details) - USD ($) $ in Millions	Sep. 30, 2018	Dec. 31, 2017
Loss Contingencies [Line Items]
Contingent liability related to performance surety bonds	$ 30
Redeemable noncontrolling interest	38	$ 38
Letter of Credit [Member]
Loss Contingencies [Line Items]
Credit line available under the agreement	$ 56

Condensed Consolidating Finan_3

Condensed Consolidating Financial Information (Condensed Consolidating Balance Sheets) (Details) - USD ($) $ in Millions	Sep. 30, 2018	Dec. 31, 2017	Dec. 31, 2016
Assets
Cash and cash equivalents	$ 2,393	$ 1,253
Receivables	187	142
Inventories:
Leaf tobacco	794	941
Other raw materials	188	170
Work in process	506	560
Finished product	589	554
Inventory, net	2,077	2,225
Due from Altria and subsidiaries	0	0
Income taxes	84	461
Other current assets	424	263
Total current assets	5,165	4,344
Property, plant and equipment, at cost	4,861	4,879
Less accumulated depreciation	2,970	2,965
Property, plant and equipment, net	1,891	1,914
Goodwill	5,307	5,307
Other intangible assets, net	12,385	12,400
Investment in AB InBev	17,825	17,952
Investment in consolidated subsidiaries	0	0
Finance assets, net	848	899
Due from Altria and subsidiaries	0	0
Other assets	532	386
Total Assets	43,953	43,202
Liabilities
Current portion of long-term debt	2,007	864
Accounts payable	289	374
Accrued liabilities:
Marketing	690	695
Employment costs	147	188
Settlement charges	3,230	2,442
Other	775	971
Dividends payable	1,508	1,258
Due to Altria and subsidiaries	0	0
Total current liabilities	8,646	6,792
Long-term debt	11,896	13,030
Deferred income taxes	5,427	5,247
Accrued pension costs	260	445
Accrued postretirement health care costs	1,983	1,987
Due to Altria and subsidiaries	0	0
Other liabilities	207	283
Total liabilities	28,419	27,784
Contingencies
Redeemable noncontrolling interest	38	38
Stockholders’ Equity
Common stock	935	935
Additional paid-in capital	5,959	5,952
Earnings reinvested in the business	43,805	42,251
Accumulated other comprehensive losses	(2,034)	(1,897)
Cost of repurchased stock	(33,171)	(31,864)
Total stockholders’ equity attributable to Altria	15,494	15,377
Noncontrolling interests	2	3
Total stockholders’ equity	15,496	15,380	$ 12,773
Total Liabilities and Stockholders’ Equity	43,953	43,202
Reportable Legal Entities [Member] | Altria Group, Inc. [Member]
Assets
Cash and cash equivalents	2,346	1,203
Receivables	0	1
Inventories:
Leaf tobacco	0	0
Other raw materials	0	0
Work in process	0	0
Finished product	0	0
Inventory, net	0	0
Due from Altria and subsidiaries	7	2
Income taxes	0	0
Other current assets	56	11
Total current assets	2,409	1,217
Property, plant and equipment, at cost	0	0
Less accumulated depreciation	0	0
Property, plant and equipment, net	0	0
Goodwill	0	0
Other intangible assets, net	0	0
Investment in AB InBev	17,825	17,952
Investment in consolidated subsidiaries	14,081	13,111
Finance assets, net	0	0
Due from Altria and subsidiaries	4,790	4,790
Other assets	159	34
Total Assets	39,264	37,104
Liabilities
Current portion of long-term debt	2,007	864
Accounts payable	0	2
Accrued liabilities:
Marketing	0	0
Employment costs	14	21
Settlement charges	0	0
Other	277	389
Dividends payable	1,508	1,258
Due to Altria and subsidiaries	4,814	3,040
Total current liabilities	8,620	5,574
Long-term debt	11,896	13,030
Deferred income taxes	2,963	2,809
Accrued pension costs	197	206
Accrued postretirement health care costs	0	0
Due to Altria and subsidiaries	0	0
Other liabilities	94	108
Total liabilities	23,770	21,727
Contingencies
Redeemable noncontrolling interest	0	0
Stockholders’ Equity
Common stock	935	935
Additional paid-in capital	5,959	5,952
Earnings reinvested in the business	43,805	42,251
Accumulated other comprehensive losses	(2,034)	(1,897)
Cost of repurchased stock	(33,171)	(31,864)
Total stockholders’ equity attributable to Altria	15,494	15,377
Noncontrolling interests	0	0
Total stockholders’ equity	15,494	15,377
Total Liabilities and Stockholders’ Equity	39,264	37,104
Reportable Legal Entities [Member] | PM USA [Member]
Assets
Cash and cash equivalents	0	1
Receivables	14	10
Inventories:
Leaf tobacco	465	579
Other raw materials	114	111
Work in process	4	5
Finished product	117	128
Inventory, net	700	823
Due from Altria and subsidiaries	4,085	2,413
Income taxes	223	542
Other current assets	334	147
Total current assets	5,356	3,936
Property, plant and equipment, at cost	2,910	2,930
Less accumulated depreciation	2,100	2,086
Property, plant and equipment, net	810	844
Goodwill	0	0
Other intangible assets, net	2	2
Investment in AB InBev	0	0
Investment in consolidated subsidiaries	2,861	2,818
Finance assets, net	0	0
Due from Altria and subsidiaries	0	0
Other assets	717	671
Total Assets	9,746	8,271
Liabilities
Current portion of long-term debt	0	0
Accounts payable	78	91
Accrued liabilities:
Marketing	578	578
Employment costs	11	14
Settlement charges	3,222	2,437
Other	335	433
Dividends payable	0	0
Due to Altria and subsidiaries	426	317
Total current liabilities	4,650	3,870
Long-term debt	0	0
Deferred income taxes	0	0
Accrued pension costs	0	0
Accrued postretirement health care costs	1,213	1,214
Due to Altria and subsidiaries	0	0
Other liabilities	30	49
Total liabilities	5,893	5,133
Contingencies
Redeemable noncontrolling interest	0	0
Stockholders’ Equity
Common stock	0	0
Additional paid-in capital	3,310	3,310
Earnings reinvested in the business	801	96
Accumulated other comprehensive losses	(258)	(268)
Cost of repurchased stock	0	0
Total stockholders’ equity attributable to Altria	3,853	3,138
Noncontrolling interests	0	0
Total stockholders’ equity	3,853	3,138
Total Liabilities and Stockholders’ Equity	9,746	8,271
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]
Assets
Cash and cash equivalents	47	49
Receivables	173	131
Inventories:
Leaf tobacco	329	362
Other raw materials	74	59
Work in process	502	555
Finished product	472	426
Inventory, net	1,377	1,402
Due from Altria and subsidiaries	1,233	1,022
Income taxes	0	17
Other current assets	34	105
Total current assets	2,864	2,726
Property, plant and equipment, at cost	1,951	1,949
Less accumulated depreciation	870	879
Property, plant and equipment, net	1,081	1,070
Goodwill	5,307	5,307
Other intangible assets, net	12,383	12,398
Investment in AB InBev	0	0
Investment in consolidated subsidiaries	0	0
Finance assets, net	848	899
Due from Altria and subsidiaries	0	0
Other assets	144	157
Total Assets	22,627	22,557
Liabilities
Current portion of long-term debt	0	0
Accounts payable	211	281
Accrued liabilities:
Marketing	112	117
Employment costs	122	153
Settlement charges	8	5
Other	302	247
Dividends payable	0	0
Due to Altria and subsidiaries	85	80
Total current liabilities	840	883
Long-term debt	0	0
Deferred income taxes	2,952	2,914
Accrued pension costs	63	239
Accrued postretirement health care costs	770	773
Due to Altria and subsidiaries	4,790	4,790
Other liabilities	83	126
Total liabilities	9,498	9,725
Contingencies
Redeemable noncontrolling interest	38	38
Stockholders’ Equity
Common stock	9	9
Additional paid-in capital	12,236	12,045
Earnings reinvested in the business	2,241	2,243
Accumulated other comprehensive losses	(1,397)	(1,506)
Cost of repurchased stock	0	0
Total stockholders’ equity attributable to Altria	13,089	12,791
Noncontrolling interests	2	3
Total stockholders’ equity	13,091	12,794
Total Liabilities and Stockholders’ Equity	22,627	22,557
Total Consolidating Adjustments [Member]
Assets
Cash and cash equivalents	0	0
Receivables	0	0
Inventories:
Leaf tobacco	0	0
Other raw materials	0	0
Work in process	0	0
Finished product	0	0
Inventory, net	0	0
Due from Altria and subsidiaries	(5,325)	(3,437)
Income taxes	(139)	(98)
Other current assets	0	0
Total current assets	(5,464)	(3,535)
Property, plant and equipment, at cost	0	0
Less accumulated depreciation	0	0
Property, plant and equipment, net	0	0
Goodwill	0	0
Other intangible assets, net	0	0
Investment in AB InBev	0	0
Investment in consolidated subsidiaries	(16,942)	(15,929)
Finance assets, net	0	0
Due from Altria and subsidiaries	(4,790)	(4,790)
Other assets	(488)	(476)
Total Assets	(27,684)	(24,730)
Liabilities
Current portion of long-term debt	0	0
Accounts payable	0	0
Accrued liabilities:
Marketing	0	0
Employment costs	0	0
Settlement charges	0	0
Other	(139)	(98)
Dividends payable	0	0
Due to Altria and subsidiaries	(5,325)	(3,437)
Total current liabilities	(5,464)	(3,535)
Long-term debt	0	0
Deferred income taxes	(488)	(476)
Accrued pension costs	0	0
Accrued postretirement health care costs	0	0
Due to Altria and subsidiaries	(4,790)	(4,790)
Other liabilities	0	0
Total liabilities	(10,742)	(8,801)
Contingencies
Redeemable noncontrolling interest	0	0
Stockholders’ Equity
Common stock	(9)	(9)
Additional paid-in capital	(15,546)	(15,355)
Earnings reinvested in the business	(3,042)	(2,339)
Accumulated other comprehensive losses	1,655	1,774
Cost of repurchased stock	0	0
Total stockholders’ equity attributable to Altria	(16,942)	(15,929)
Noncontrolling interests	0	0
Total stockholders’ equity	(16,942)	(15,929)
Total Liabilities and Stockholders’ Equity	$ (27,684)	$ (24,730)

Condensed Consolidating Finan_4

Condensed Consolidating Financial Information (Condensed Consolidating Statements of Earnings and Comprehensive Earnings) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Condensed Income Statements, Captions [Line Items]
Net revenues	$ 6,837	$ 6,729	$ 19,250	$ 19,475
Cost of sales	2,037	1,952	5,509	5,719
Excise taxes on products	1,545	1,606	4,409	4,695
Gross profit	3,255	3,171	9,332	9,061
Marketing, administration and research costs	700	574	1,959	1,681
Asset impairment and exit costs	(2)	8	2	24
Operating (expense) income	2,557	2,589	7,371	7,356
Interest and other debt expense (income), net	159	169	503	525
Net periodic benefit income, excluding service cost	(21)	(18)	(37)	(37)
Earnings from equity investment in AB InBev	(189)	(169)	(759)	(332)
Loss (gain) on AB InBev/SABMiller business combination	0	(37)	33	(445)
Earnings before income taxes and equity earnings of subsidiaries	2,608	2,644	7,631	7,645
(Benefit) provision for income taxes	664	777	1,915	2,386
Equity earnings of subsidiaries	0	0	0	0
Net earnings	1,944	1,867	5,716	5,259
Net earnings attributable to noncontrolling interests	(1)	(1)	(3)	(3)
Net earnings attributable to Altria	1,943	1,866	5,713	5,256
Net earnings	1,944	1,867	5,716	5,259
Other comprehensive (losses) earnings, net of deferred income taxes	(382)	(108)	(137)	106	$ 155
Comprehensive earnings	1,562	1,759	5,579	5,365
Comprehensive earnings attributable to noncontrolling interests	(1)	(1)	(3)	(3)
Comprehensive earnings attributable to Altria	1,561	1,758	5,576	5,362
Reportable Legal Entities [Member] | Altria Group, Inc. [Member]
Condensed Income Statements, Captions [Line Items]
Net revenues	0	0	0	0
Cost of sales	0	0	0	0
Excise taxes on products	0	0	0	0
Gross profit	0	0	0	0
Marketing, administration and research costs	45	46	122	125
Asset impairment and exit costs	0	0	0	0
Operating (expense) income	(45)	(46)	(122)	(125)
Interest and other debt expense (income), net	127	122	378	375
Net periodic benefit income, excluding service cost	1	0	3	1
Earnings from equity investment in AB InBev	(189)	(169)	(759)	(332)
Loss (gain) on AB InBev/SABMiller business combination		(37)	33	(445)
Earnings before income taxes and equity earnings of subsidiaries	16	38	223	276
(Benefit) provision for income taxes	21	(167)	67	(207)
Equity earnings of subsidiaries	1,948	1,661	5,557	4,773
Net earnings	1,943	1,866	5,713	5,256
Net earnings attributable to noncontrolling interests	0	0	0	0
Net earnings attributable to Altria	1,943	1,866	5,713	5,256
Net earnings	1,943	1,866	5,713	5,256
Other comprehensive (losses) earnings, net of deferred income taxes	(382)	(108)	(137)	106
Comprehensive earnings	1,561	1,758	5,576	5,362
Comprehensive earnings attributable to noncontrolling interests	0	0	0	0
Comprehensive earnings attributable to Altria	1,561	1,758	5,576	5,362
Reportable Legal Entities [Member] | PM USA [Member]
Condensed Income Statements, Captions [Line Items]
Net revenues	5,811	5,764	16,339	16,748
Cost of sales	1,736	1,668	4,666	4,888
Excise taxes on products	1,491	1,551	4,245	4,533
Gross profit	2,584	2,545	7,428	7,327
Marketing, administration and research costs	491	422	1,400	1,223
Asset impairment and exit costs	0	0	0	0
Operating (expense) income	2,093	2,123	6,028	6,104
Interest and other debt expense (income), net	(20)	(6)	(37)	(12)
Net periodic benefit income, excluding service cost	(18)	(14)	(33)	(28)
Earnings from equity investment in AB InBev	0	0	0	0
Loss (gain) on AB InBev/SABMiller business combination		0	0	0
Earnings before income taxes and equity earnings of subsidiaries	2,131	2,143	6,098	6,144
(Benefit) provision for income taxes	539	776	1,537	2,173
Equity earnings of subsidiaries	119	82	310	234
Net earnings	1,711	1,449	4,871	4,205
Net earnings attributable to noncontrolling interests	0	0	0	0
Net earnings attributable to Altria	1,711	1,449	4,871	4,205
Net earnings	1,711	1,449	4,871	4,205
Other comprehensive (losses) earnings, net of deferred income taxes	2	3	10	10
Comprehensive earnings	1,713	1,452	4,881	4,215
Comprehensive earnings attributable to noncontrolling interests	0	0	0	0
Comprehensive earnings attributable to Altria	1,713	1,452	4,881	4,215
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]
Condensed Income Statements, Captions [Line Items]
Net revenues	1,035	974	2,938	2,754
Cost of sales	310	293	870	858
Excise taxes on products	54	55	164	162
Gross profit	671	626	1,904	1,734
Marketing, administration and research costs	164	106	437	333
Asset impairment and exit costs	(2)	8	2	24
Operating (expense) income	509	512	1,465	1,377
Interest and other debt expense (income), net	52	53	162	162
Net periodic benefit income, excluding service cost	(4)	(4)	(7)	(10)
Earnings from equity investment in AB InBev	0	0	0	0
Loss (gain) on AB InBev/SABMiller business combination		0	0	0
Earnings before income taxes and equity earnings of subsidiaries	461	463	1,310	1,225
(Benefit) provision for income taxes	104	168	311	420
Equity earnings of subsidiaries	0	0	0	0
Net earnings	357	295	999	805
Net earnings attributable to noncontrolling interests	(1)	(1)	(3)	(3)
Net earnings attributable to Altria	356	294	996	802
Net earnings	357	295	999	805
Other comprehensive (losses) earnings, net of deferred income taxes	36	27	109	83
Comprehensive earnings	393	322	1,108	888
Comprehensive earnings attributable to noncontrolling interests	(1)	(1)	(3)	(3)
Comprehensive earnings attributable to Altria	392	321	1,105	885
Total Consolidating Adjustments [Member]
Condensed Income Statements, Captions [Line Items]
Net revenues	(9)	(9)	(27)	(27)
Cost of sales	(9)	(9)	(27)	(27)
Excise taxes on products	0	0	0	0
Gross profit	0	0	0	0
Marketing, administration and research costs	0	0	0	0
Asset impairment and exit costs	0	0	0	0
Operating (expense) income	0	0	0	0
Interest and other debt expense (income), net	0	0	0	0
Net periodic benefit income, excluding service cost	0	0	0	0
Earnings from equity investment in AB InBev	0	0	0	0
Loss (gain) on AB InBev/SABMiller business combination		0	0	0
Earnings before income taxes and equity earnings of subsidiaries	0	0	0	0
(Benefit) provision for income taxes	0	0	0	0
Equity earnings of subsidiaries	(2,067)	(1,743)	(5,867)	(5,007)
Net earnings	(2,067)	(1,743)	(5,867)	(5,007)
Net earnings attributable to noncontrolling interests	0	0	0	0
Net earnings attributable to Altria	(2,067)	(1,743)	(5,867)	(5,007)
Net earnings	(2,067)	(1,743)	(5,867)	(5,007)
Other comprehensive (losses) earnings, net of deferred income taxes	(38)	(30)	(119)	(93)
Comprehensive earnings	(2,105)	(1,773)	(5,986)	(5,100)
Comprehensive earnings attributable to noncontrolling interests	0	0	0	0
Comprehensive earnings attributable to Altria	$ (2,105)	$ (1,773)	$ (5,986)	$ (5,100)

Condensed Consolidating Finan_5

Condensed Consolidating Financial Information (Condensed Consolidating Statements of Cash Flows) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash Provided by Operating Activities
Net cash provided by operating activities	$ 6,566	$ 4,144
Cash Provided by (Used in) Investing Activities
Capital expenditures	(132)	(151)
Proceeds from finance assets	0	133
Other	(5)	(184)
Net cash used in investing activities	(137)	(202)
Cash Provided by (Used in) Financing Activities
Repurchases of common stock	(1,317)	(2,359)
Dividends paid on common stock	(3,909)	(3,544)
Changes in amounts due to/from Altria and subsidiaries	0	0
Cash dividends paid to parent	0	0
Other	(25)	(47)
Net cash used in financing activities	(5,251)	(5,950)
Cash, cash equivalents and restricted cash:
Increase (decrease)	1,178	(2,008)
Balance at beginning of period	1,314	4,651
Balance at end of period	2,492	2,643
Reportable Legal Entities [Member] | Altria Group, Inc. [Member]
Cash Provided by Operating Activities
Net cash provided by operating activities	4,806	4,777
Cash Provided by (Used in) Investing Activities
Capital expenditures	0	0
Proceeds from finance assets		0
Other	8	(4)
Net cash used in investing activities	8	(4)
Cash Provided by (Used in) Financing Activities
Repurchases of common stock	(1,317)	(2,359)
Dividends paid on common stock	(3,909)	(3,544)
Changes in amounts due to/from Altria and subsidiaries	1,576	(813)
Cash dividends paid to parent	0	0
Other	(21)	(40)
Net cash used in financing activities	(3,671)	(6,756)
Cash, cash equivalents and restricted cash:
Increase (decrease)	1,143	(1,983)
Balance at beginning of period	1,203	4,521
Balance at end of period	2,346	2,538
Reportable Legal Entities [Member] | PM USA [Member]
Cash Provided by Operating Activities
Net cash provided by operating activities	5,801	3,664
Cash Provided by (Used in) Investing Activities
Capital expenditures	(33)	(21)
Proceeds from finance assets		0
Other	0	2
Net cash used in investing activities	(33)	(19)
Cash Provided by (Used in) Financing Activities
Repurchases of common stock	0	0
Dividends paid on common stock	0	0
Changes in amounts due to/from Altria and subsidiaries	(1,565)	182
Cash dividends paid to parent	(4,166)	(3,849)
Other	0	0
Net cash used in financing activities	(5,731)	(3,667)
Cash, cash equivalents and restricted cash:
Increase (decrease)	37	(22)
Balance at beginning of period	62	83
Balance at end of period	99	61
Reportable Legal Entities [Member] | Non-Guarantor Subsidiaries [Member]
Cash Provided by Operating Activities
Net cash provided by operating activities	1,123	639
Cash Provided by (Used in) Investing Activities
Capital expenditures	(99)	(130)
Proceeds from finance assets		133
Other	(13)	(182)
Net cash used in investing activities	(112)	(179)
Cash Provided by (Used in) Financing Activities
Repurchases of common stock	0	0
Dividends paid on common stock	0	0
Changes in amounts due to/from Altria and subsidiaries	(11)	631
Cash dividends paid to parent	(998)	(1,087)
Other	(4)	(7)
Net cash used in financing activities	(1,013)	(463)
Cash, cash equivalents and restricted cash:
Increase (decrease)	(2)	(3)
Balance at beginning of period	49	47
Balance at end of period	47	44
Total Consolidating Adjustments [Member]
Cash Provided by Operating Activities
Net cash provided by operating activities	(5,164)	(4,936)
Cash Provided by (Used in) Investing Activities
Capital expenditures	0	0
Proceeds from finance assets		0
Other	0	0
Net cash used in investing activities	0	0
Cash Provided by (Used in) Financing Activities
Repurchases of common stock	0	0
Dividends paid on common stock	0	0
Changes in amounts due to/from Altria and subsidiaries	0	0
Cash dividends paid to parent	5,164	4,936
Other	0	0
Net cash used in financing activities	5,164	4,936
Cash, cash equivalents and restricted cash:
Increase (decrease)	0	0
Balance at beginning of period	0	0
Balance at end of period	$ 0	$ 0

Recent Accounting Guidance No_3

Recent Accounting Guidance Not Yet Adopted (Narrative) (Details)	9 Months Ended
	Sep. 30, 2018
Accounting Standards Update 2016-13 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Percentage of assets within scope	2.00%

Uncategorized Items - mo-201809

Label	Element	Value	[1]
Restricted Cash, Noncurrent	us-gaap_RestrictedCashNoncurrent	$ 36,000,000
Restricted Cash, Noncurrent	us-gaap_RestrictedCashNoncurrent	40,000,000
Restricted Cash, Current	us-gaap_RestrictedCashCurrent	25,000,000
Restricted Cash, Current	us-gaap_RestrictedCashCurrent	$ 59,000,000
[1]	Restricted cash consisted of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals. See Note 10. Contingencies.